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Abstract
Assessment of Protein Quality, Lipid Metabolism, Hepatic Transcriptome and Safety of a Silver
Carp (Hypophthalmichthys molitrix) Derived Sarcoplasmic Protein Powder.
Derek C. Warren
Fishery resources are currently operating either near optimal yield or at levels with elevated risk for fish
stock depletion. A solution for overcoming limitations of natural fish resources is through utilization of
less desirable fish species and fish processing by-products. Water-soluble sarcoplasm proteins consist of
25 – 30% of protein in carp, are lost in wash water during processing and can be recovered and freezedried to produce a protein-rich powder (CSP). However, protein quality and safety of CSP must be
evaluated prior to commercial use. High quality proteins are sought after in order to lower the amount of
protein consumed for protein synthesis. Not only does this contribute to sustainability, but whey-based
infant formulas with high protein content have been reported to increase body weight gain and risk of
obesity at adulthood. However, low protein intake can risk protein-energy malnutrition characterized by
fatty liver and hepatic dysfunction due to altered lipid metabolism.
The objective of this project was: 1) to evaluate the protein quality of CSP and effects of low (10% kcal)
protein diets on growth, body composition, renal and bone health, 2) to assess low protein (10 % kcal)
diets consisting of CSP or commercial milk proteins effects on lipid metabolism in liver and adipose
tissue compared to a protein deficient diet, and 3) to investigate distinct phenotypic and hepatic
transcriptome responses to low protein (10% kcal) diets consisting of CSP, casein, and whey protein
using a growing animal model. Young (age 28 days) female Sprague-Dawley rats were randomly
assigned (n=8 rats/group) to standard purified diets consisting of 10% protein as CSP, casein, whey
protein or a protein-free diet.
Results showed greater (p < 0.05) fecal amino acid excretion in casein-fed rats, but no significant
differences in liver and muscle amino acid profiles among protein diets. All low protein diets supported
growth within the normal range, but whey protein-fed rats had greater (p < 0.05) adiposity. CSP, whey
and casein-fed rats showed no differences in serum renal biomarkers or bone indices. In the liver, rats fed
protein-free diet had the highest (p < 0.05) total hepatic lipid content and highest histological evidence of
hepatocyte fat infiltration. Rats consuming CSP showed no differences in hepatic weight, fat infiltration,
and lipid metabolism biomarkers compared to casein and whey-fed rats. There was no effect of CSP on
inflammation; however, pro-inflammatory cyclooxygenase-2 was upregulated (p < 0.05) in adipose tissue
of casein-fed rats which was balanced by upregulation of anti-inflammatory interleukin-10 response.
Further, hepatic lipoprotein lipase was upregulated (p < 0.05) in rats consuming casein in response to
cytokine production. RNA sequencing of hepatic tissue was performed to further investigate.
Consumption of protein-free diet resulted in the greatest number (1,814) of differentially expressed genes
compared to casein diet. Abundance of IGF-1 transcripts were greater (p < 0.05) in CSP and whey
protein-fed rats. IGF-1 has been shown to illicit anabolic metabolism increasing the propensity for greater
adiposity that was observed in whey-fed rats.
Collectively, results indicate protein quality of CSP is comparable to casein. Based on studies
investigating kidney and bone health and detailed studies on hepatic lipid metabolism and gene
expression, providing low protein diets consisting of CSP as the protein source is a physiologically safe
option and may be preferable to whey protein for preventing increased adiposity. Further, recovery of
CSP from an invasive fish species could be marketed as a sustainable alternative to current commercial
protein powders.
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Chapter I
Introduction

As of 2016, the Fishes and Aquaculture Organization (FAO) reported global aquaculture
growth declined by 3.3% meanwhile the human population continues to increase by 1.6%,
annually, with an expected global population of 10 billion by 2050. Currently, fishery resources
are operating either near optimal yield or at levels with elevated risk for fish stock depletion
(FAO, 2016). A solution for overcoming limitations of natural fish resources is through
utilization of less desirable fish species and nutrient dense fish processing by-products.
Silver carp (Hypophthalmichthys molitrix) was imported to the United States in the 1970s for
use as filter feeders in aquaculture. Since their unintentional introduction into the wild, silver
carp are an invasive species causing decimation of freshwater ecosystems by out competing
native fish species for phytoplankton. This resulted in negative impacts on the food chain in
North American freshwater river systems (Chick, 2001). Yet, carp is composed of 7.13% fat,
consisting mainly of the health beneficial long-chain omega-3 polyunsaturated fatty acids (n-3
PUFAs) (Ljubojević et al., 2017), and 16.69% protein, comprising all the essential amino acids
required by adults and children (Skibniewska, 2013). Silver carp’s abundance and nutritional
composition makes it a sustainable fish species.
Previous research reported that silver carp sarcoplasmic proteins solubilized in wash water
can be recovered and freeze-dried into a protein-rich powder (Warren et al., 2018). However, the
protein quality and safety of this novel protein supplement needs to be evaluated before CSP can
be commercialized. Wibowo and colleagues (2007) compared sarcoplasm protein powder
recovered by chitosan-alginate precipitation from surimi wash water to casein and commercial
protein meals. Water soluble protein recovered from surimi wash water was determined to be
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higher in protein quality than casein and commercial protein meals. Additionally, the recovered
protein was considered safe based on an absence of significant changes in blood chemistry
measurements after feeding 18% kcal protein to male rats aged 40 days for 20 days during the
pubescent stage. In our study, reduced protein (10% kcal) diets and female rats were used to
investigate whether lower protein content may reduce the risk of obesity and renal damage.
However, low protein diets may be inadequate during the growth stage.
Protein-energy malnutrition is defined as an imbalance between protein and energy intake
and the amount required for optimal growth, development, and function (Fock et al., 2010;
Bossola, 2015). Protein-energy malnutrition has been reported to alter liver histology and
biochemical characteristics ultimately, leading to fatty liver and hepatic dysfunction (Caballero
et al., 2015; Feres et al., 2010, Zutphen et al., 2016). When dietary protein content is reduced
protein quality and digestibility becomes more important for sustaining growth and metabolic
function. Koletzko and others (2009) found infants fed diets with lower inclusion of higher
quality proteins reduced the risk of later in life obesity development. However, infant formulas
often have higher protein content compared to human milk and have been related to weight gain
and obesity later-in-life (Tang, 2018). Further, a European multi-centered clinical study reported
infants receiving a high protein formula had a greater kidney volume compared to infants
receiving a low protein formula or breastfed infants. Higher kidney volume was attributed to
increased renal workload indicated by greater serum urea/creatinine ratios (Escribano et al.,
2011).
Ong and others (2009) reported greater body weight gains in formula-fed infants compared to
infants fed human milk due to increased insulin like growth factor 1 (IGF-1) and insulin
excretion. Hepatic secretion of IGF-1 is dependent on nutritional status and hormones such as
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insulin (Daughaday and Rotwin, 1989). Diets low in protein have been shown to decrease plasma
concentrations of IGF-1 in growing pigs (Deng et al., 2007). While dietary branch chain amino
acids (e.g. leucine, isoleucine, valine) have been reported to induce IGF-1 excretion. Wang et al.
(2017) reported greater expression of IGF-1 from amino acid supplementation because of an
interaction between mammalian target of rapamycin (mTOR), an important intracellular sensor
for cell growth and autophagy, and peroxisome proliferator-activated receptor gamma (PPARγ),
a transcription factor involved in the regulation of lipolysis. Song and others (2016) reported
supplementation of protein sources from beef, chicken, pork and carp in the recommended
amount (18% by weight) for seven days resulted in distinct gene expression and physiological
responses. Carp protein consumption was shown to down-regulate genes regulating fatty acid
oxidation and the synthesis of bile acids, triglycerides, and cholesterol with other proteins
altering insulin secretion.
Therefore, the objectives of this research project were:
1) To evaluate the protein quality of CSP and effects of lower (10% kcal) protein diets on
growth, body composition, renal markers, and bone health in a rat model.
2) To assess low protein (10 % kcal) diets from CSP and two common commercial protein
powders (casein and whey protein) effects on lipid metabolism in hepatic and adipose tissue
compared to a protein-energy malnutrition diet.
3) To investigate distinct phenotypic and hepatic transcriptome responses due to low protein
(10% kcal) diets supplemented with CSP and milk proteins, casein and whey, in a growing
animal model.
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Chapter II
Literature Review
Literature Review
1. Introduction
As of 2016, global fisheries have been operating close to maximal levels risking depleting
fish stock (FAO, 2016). According to the Fishes and Aquaculture Organization, expansion of
aquaculture industries has decreased by 3.3 percent while the global population is expected to
reach 10 billion by 2050 (FAO, 2016). Natural resources, such as fish stock, have innate
limitations. However, solutions can be developed to overcome these innate limitations such as
redirecting fish processing by-products or by using a less desirable fish species.
Silver carp (Hypophthalmichthys molitrix) was initially brought into the United States during
the 1970s as an algal control measure in aquaculture and sewage treatment ponds. Flooding in
the 1980s resulted in the introduction of silver carp to the Mississippi River. Since their
unintended introduction, silver carp have been reported in many rivers, lakes, and tributaries of
the Mississippi River (Chick 2001). Due to a lack of natural predators in United States
waterways, silver carp continue to spread into other habitats, severely disrupting existing
ecosystems (Chick 2001). Despite their abundance, silver carp are underutilized due to their
boniness that makes consumption and fish processing difficult. A proposed solution to the
problem of overabundance of this invasive fish species is to use silver carp as a protein source
for human consumption.
Silver carp contain all 10 essential amino acids in quantities that are ideal for human needs
(Ljubojević 2017). The protein and lipid composition of wild carp are 16.69% and 7.13%,
respectively. Further, 72.64% of fatty acids consist of polyunsaturated fatty acids (PUFAs) with
the health-beneficial omega-3 PUFAs (ω-3 PUFAs) being particularly abundant at 5.97%
7

(Ljubojević 2017). Previous research in our laboratory investigated the recovery, drying, and in
vitro characteristics of a protein-rich silver carp sarcoplasmic protein powder; however, in vivo
quality and safety was not considered (Warren et al. 2018).
The purpose of this literature review is to provide an overview of the limited published
studies that have investigated nutritional quality of aquatic proteins compared to other
commercial sources. Additionally, studies focused on safety of low protein diets will be
reviewed due to the initiative to reduce the protein content of infant formulas to prevent
childhood obesity without causing protein energy malnutrition that can result in in stunted
growth and NAFLD.
2. Aquatic Protein Nutritional Quality
The nutritional value of protein-peptide hydrolysate (PPH) material derived from hairtail
fish was evaluated in a study by Ding and colleagues (2016). Soluble proteins were extracted
from imitated surimi wash water then freeze-dried. The proximate composition of the surimi
wash water showed the wash-water contained 8.19 ± 0.10 mg/ml dry matter, 0.54 ± 0.01 mg/ml
(6.5%) lipid, and 6.68 ± 0.04 mg/ml (81.5%) crude protein. Water soluble proteins (2.26 ± 0.01
mg/ml) were mainly composed of sarcoplasmic proteins. Flavoring compounds (aldehydes,
ketones, alcohols, hydrocarbons, and heterocyclic compounds), oligopeptides and free amino
acids, were the main components of the non-protein nitrogen (1.92 ± 0.01 mg/ml). There were no
differences in crude protein concentration and dry matter between the initial surimi wash water
(6.78 ± 0.04) and recovered PPH (6.74 ± 0.06 mg/ml). The composition of water-soluble
proteins and nonprotein nitrogen for PPH was 2.81 ± 0.051 and 3.94 ± 0.064 mg/ml. This was
higher than the water-soluble protein (2.26 ± 0.009 mg/ml) and non-protein nitrogen (1.92 ± 0.01
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mg/ml) identified in the surimi wash water. This was attributed to the degradation of fish
particles during hydrolysis.
The recovered PPH contained all the essential amino acids needed by humans, which
accounted for 44.1 % of total amino acids with total amino acid accounting for 78.2 % of the dry
matter. High levels of nonessential amino acids were also detected in the recovered proteinpeptide material. The FAO/WHO essential amino acid requirements and comparison to whole
egg protein were used to determine nutritional value. The amino acid score for the recovered
PPH was greater than the FAO/WHO essential amino acid requirements. Methionine + cysteine
was the first limiting amino acid. An essential amino acid index of 101.7 (>95), indicated that the
recovered protein-peptide material has comparable nutritional value to standard whole egg
protein. The biological value (BV) of the recovered PPH (BV 76.7) was greater than that of
wheat (BV 67), peanuts (BV 59), and pork (BV 74) with beef (BV 76). Collectively, study
results indicated that recovered PPH extracted from wash water possesses a high nutritional
value (Ding et al., 2016). However, these protein quality calculations did not take the
bioavailability of recovered proteins into account.
Wibowo and others (2007) determine the safety and nutritional value of the recovered
surimi wash water protein. Surimi wash water was collected, solids removed, and then treated
with Chitosan-Alginate (Chi-Alg) to coagulate the soluble proteins in the wash water. Proximate
composition and amino acid analysis were conducted on the freeze-dried recovered surimi wash
water protein and compared to commercial protein meal sources. Proximate composition showed
freeze-dried recovered protein had the higher crude protein content of 73.1 ± 1.67% (68.93% on
wet basis) compared to herring, menhaden, soybean, and corn gluten meals, with 66.50%,
58.86%, 43.21% and 62.45% protein on a wet basis, respectively.
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Among the fish-based commercial protein meals, recovered surimi wash water protein
had higher carbohydrate content (3.39%) compared to 1.3 and 2.9% reported in the herring and
menhaden feeds, respectively. Lipid content in surimi wash water was 8.11% compared to
herring and menhaden fish protein meals with 8.0 and 7.8% lipid, respectively. Surimi wash
water protein had higher lipid content compared to soybean (3.1%) and corn gluten (1.7%)
meals. Total reported essential amino acid for the surimi wash water protein and four protein
meals were 51.8%, 35.4% (herring), 41.4% (menhaden), 25.4% (soybean), and 42.8% (corn
gluten), repressively. The amino acid profile showed surimi wash water contained greater
concentrations of all measured essential amino acids compared to herring, menhaden, soybean,
and corn gluten commercial meal sources. The tryptophan content for surimi wash water protein
and commercially available meals were not reported. Collectively, results indicated surimi wash
water protein was nutrient rich and comparable to commercially available feed-protein sources,
in terms of crude protein composition and essential amino acid content (Wibowo et al., 2007).
Another study investigated recovery of protein from a novel source not using the Chi-Alg
method. Protein was recovered from whole krill using isoelectric solubilization-precipitation
producing a protein concentrate (Gigliotti et al., 2008). Krill (a species of pelagic crustaceans)
are estimated to consist of the largest multi-cellular aquatic biomasses. Typically, krill consist of
60 – 80% protein, 7 - 26% lipid, and 12 – 17% ash on a dry basis. Isoelectric solubilization
precipitation recovered approximately 46% of protein from krill producing a protein concentrate
composed of 77.7% protein, 8.1% lipid, and 4.4% ash (on a dry basis). The FAO/WHO/UNU
amino acid requirements were used to compare the amino acids profile to human adult and infant
requirements. All nine essential amino acids were present in sufficient amounts to meet the
FAO/WHO/UNU amino acid requirements. Additionally, the krill protein concentrate contained
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greater (p<0.05) amounts of protein and total essential amino acids compared to whole krill at
531.5 mg/g and 212.1 mg/g, respectfully.
Following amino acid evaluation of recovered protein, diets containing 10% krill protein
concentrate or casein were fed to growing (age 28 d) female rats to characterize in vivo
bioavailability and protein quality. No differences were found in body weight among the protein
groups following four weeks of feeding. Results indicated krill protein concentrate was a
complete protein comparable in quality to casein. No significant differences were reported
among the protein quality measurements: true digestibility, biological value, net protein
utilization, protein digestibility corrected amino acid score, and protein efficiency ratio.
Collectively, results showed similar protein quality for krill protein concentrate and casein
(Gigliotti et al., 2008).
Previous research in our laboratory investigated the effect of separation temperature on in
vitro nutritional quality of a soluble protein derived from silver carp (Warren et al., 2018). Water
soluble proteins were recovered from homogenized silver carp using dilution, homogenization,
and centrifugation. The recovered protein wash water was freeze-dried and powdered for
analysis. The recovered silver carp sarcoplasmic protein powder (CSP) contained approximately
82% protein, 4% lipid and 15% ash. The high mineral content was due to minerals commonly
stored in bone and cartilage being release during homogenization.
Fatty acid profiling showed CSP contained mainly saturated fatty acids (31%) and
monounsaturated fatty acids (27%) with polyunsaturated fatty acids composing 13% of total
lipids. The amino acid profile of the CSP was compared to the FAO/WHO/UNU adult and infant
amino acid requirement. CSP met all amino acid requirements for adults; however, amino acid
requirements set for infants were not met due to low contents of some branched chain amino
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acids (isoleucine and leucine) and sulfur amino acids (cysteine and methionine). Warren et al.
(2018) suggested proteins derived from silver carp could be a nutritious source of amino acids
and micronutrients. However, these data do not consider safety or bioavailability of the protein
powder. Collectively, results of these studies indicate protein derived from aquatic sources are
nutritious; however, bioavailability and safety also need to be addressed.
3. Proteins and Renal Health
For approval of commercial use, the safety of novel protein supplements must be evaluated.
Studies have found an association between protein consumption and the development of renal
disease (Friedman, 2004). Consumption of chronic and acute high protein diets showed an
increase in glomerular filtrations rates and renal blood flow, increasing risk of kidney stress and
potential for renal damage (Martin et al., 2005). In the clinical setting, individuals diagnosed
with renal disease are advised to follow a standard dietary recommendation is to restrict the
consumption of proteins (Martin et al., 2005). A study consisting of participants with no prior
history of kidney disease found estimated glomerular filtration rate (eGFR) increased (p<0.05) in
participants consuming a diet in which 10% of kilocalories from carbohydrates were replaced by
protein (referred to as a protein emphasized diet). The eGFR scores were higher in participants
consuming the protein emphasized diet as compared to diets with elevated carbohydrate and
unsaturated fat diets. Due to potential health risks to participants, the study was discontinued and
therefore, unable to analyze the effects of long-term, high protein diets (Juraschek et al., 2013).
The effects of a high and low protein intake on kidney health was investigated in a European
multi-centered clinical study. Participants consisted of formula-fed infants (n=601) enrolled in a
1-year long program and randomly assigned to either a low-protein (1.94 ±0.46 g/kg) or highprotein (3.0 ±0.7 g/kg per day) formula (Escribano et al., 2011). Results indicated infants
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receiving the high protein formula had greater (p<0.05) kidney volumes, serum urea, and urea to
creatinine ratios compared to infants receiving a low protein formula or breastmilk. Higher
kidney volume was attributed to the increased renal workload indicated by greater serum
urea/creatinine ratios. There were no differences were found among infants fed the low-protein
formula compared to breast-fed infants (Escribano et al., 2011). Due to ethical consideration in
conducting studies using infant and growing children, studies have mainly evaluated
consumption of proteins from different sources on renal health using animal models.
Diet-induced nephrocalcinosis is a common occurrence in female rats (Rao, 2002). The
transition of nephrocalcinosis to nephrolithiasis was implicated in nephropathy and subsequent
renal failure in rats (Jara et al., 2004). Gigliotti et al. (2008) compared feeding a low protein
(10% kcal) diets consisting of krill protein concentrate and casein to growing female rats. Rats
fed krill protein concentrate consumption had lower (p < 0.05) kidney weights compared to
casein. Additionally, total renal mineral content was lower (p < 0.001) in rats fed krill protein
concentrate (0.07 g/g kidney) compared to rats fed casein (0.3 g/g kidney). The study results
suggested feeding different protein sources influenced mineral deposition in the kidney with krill
protein concentration reducing renal calcification. Gigliotti et al. (2010), further investigated the
pathogenesis of renal mineralization and renal calcium deposition in casein fed rats found krill
protein concentrate prevented early renal injury by modulating urinary n-acetyl glucosaminidase
activity, renal mineralization, and proteinuria while improving glomerular filtration rates. In
addition to protein, other bioactive nutrients in the krill protein concentrate, ω-3 PUFAs, also
appeared to have renal protective effects. Collectively, the studies by Gigliotti and colleagues
(2008; 2010) provided evidence that low protein diet consisting of aquatic sourced proteins
attenuated diet-induced renal injury and improved function.
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Zhang and Beynan (1992) supplemented growing female rats protein diets sourced from
soybean, casein, or cod meal at doses consisting of 2.40, 4.79 or 7.19 g nitrogen/100 g for 3
weeks. Lower kidney calcium concentrations (p<0.05) were found in rats fed cod meal compared
to soybean and casein-fed rats. Furthermore, evidence of nephrocalcinosis was absent when renal
histology was examined indicating consumption of cod meal had minimal effects of renal health.
Wibowo et al. (2007) compared sarcoplasmic protein powder recovered by chitosan-alginate
precipitation from surimi wash water to casein and commercial protein meals. While protein
recovered from surimi wash water was determined to be higher in protein quality than casein and
commercial protein meals, residual chitosan has been associated with safety issues such as
enlargement of the kidneys. Consumption of surimi wash water extracted with chitosan resulted
in greater (p<0.05) final kidney weights compared to the standard casein and casein-chitosan
diets group of 1.4g, 1.2g and 1.2g, respectfully. Although renal histology and mineral content
was not quantified; there were no significant differences in blood biomarkers kidney functions.
These results support the safety of surimi wash water protein recovered using chitosan-alginate
precipitation (Wibowo et al., 2007). Collectively, studies provide support for safety and
potentially protective effects of aquatic protein consumption on renal health. To the best of our
knowledge, no studies have been conducted to determine the safety of carp derived sarcoplasmic
protein recovered from wash water on renal health.
Another safety concern is kidney damage as it reduces the body’s ability to buffer acids
produced during protein metabolism. Particularly, sulfur amino acids may cause skeletal tissue to
liberate its calcium stores which alters the structural rigidity of bone (Cuenca-Sanchez et al.,
2015). Therefore, it is important to evaluate the effect of consuming protein from novel sources
on bone health.
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4. Protein and Bone Health
Both high and low protein diets can be detrimental for bones. When high protein diets are
consumed, the kidneys may be unable to neutralize the acid load produced in amino acid
metabolism. In order to buffer increased acid load, bone release stored carbonate and calcium
which can affect long-term bone health (Cuenca-Sanchez et al., 2015). Subsequently, release of
calcium stores from bone and increased calcium excretion results in bone loss which increases
the risk of osteoporosis (Cuenca-Sanchez et al., 2015).
Low protein diets may also be detrimental to bones. Kerstetter and colleagues (2003)
reported low dietary protein intake correlated with reduced bone density and increased rates of
bone loss. Further, reduced bone density and structure during the growth and development stage
increases risk of osteoporosis in adulthood (Gordon et al., 2017).
Animal models have been used to evaluate novel protein sources. Rats fed 10% krill protein
concentrate and casein showed no differences in bone morphometry and bone strength (Gigliotti
et al., 2010). These results may be due to krill protein concentrate containing high concentrations
of calcium and phosphorous. Calcium and phosphorous are critical for formation of
hydroxyapatite which provide mechanical resistance of the organic bone matrix (Bonjour, 2011).
Similarly, Fournier et al., (2014) fed low protein (5% kcal casein) diets containing calcium
(0.2%) and phosphorous (0.16%) to growing Sprague-Dawley female rats for eight weeks.
Results indicated supplementation of calcium and phosphorous attenuated the reduction in bone
mass and strength typically related to low protein diet consumption.
Dietary protein is metabolized to urea for excretion by the kidneys (Friedman, 2004) and
therefore, high protein intakes may contribute to both kidney and liver injury and over the long

15

term reduced function. Alternatively, protein energy malnutrition has been observed to cause
fatty liver (Kumar et al.,1972).
5. Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is defined as steatosis of the liver that is not
caused by alcohol consumption. NAFLD among of the most prevalent liver diseases in adults
worldwide. Additionally, the prevalence of NAFLD in children is also increasing (Munteanu et
al., 2016; Temple et al., 2016). NAFLD is diagnosed by light microscopic examination of
hematoxylin and eosin stained liver sections (4–5 μm thick) showing fat vacuoles in > 5% of
hepatocytes (Sanyal et al., 2011).
The dysregulation of hepatic lipid metabolism is illustrated in Figure 1 (Millar et al., 2013).
Briefly, the mechanism in NAFLD may be due to enhance de novo lipogenesis (DNL) by
nutrients stimulating transcription factors involved in the DNL pathway (Strable et al 2010; Naik
et al., 2013). Fatty acid synthetase (FAS) is activated by transcription factor sterol regulatory
binding protein-1c (SREBP-1c) and carbohydrate element response binding protein (ChREBP).
FAS produces saturated fatty acids and stearoyl-CoA desaturase (SCD-1) removes hydrogens
from saturated fatty acids producing monounsaturated fatty acids (MUFAs). De novo synthesized
fatty acids are used for synthesis of triglycerides. The rate limiting enzyme in by de novo
synthesis of triglycerides is diacylglycerol O-acyl transferase-2 (DGAT2). Endogenous
triglycerides either remain in the liver, or following activation of microsomal triglyceride
transport protein (MTTP) are transported to extrahepatic tissue in very-low density lipoprotein
(VLDL). In the circulation, VLDL interact with lipoprotein lipase (LPL) in peripheral tissues
such as adipose tissue. LPL removes triglycerides from VLDL to be used in energy production or
for storage (Feingold et al., 2018).
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While the etiology of NAFLD is often associated with poor diets containing high amounts of
saturated fatty acids and simple carbohydrates, dietary protein has also been shown to affect
NAFLD. In 1972, Kumar et al. (1972) reported rhesus monkeys provided protein restricted diets
developed fatty liver due to enhanced hepatic triglycerides and had reduced serum triglycerides
and phospholipids. Results indicated protein deficient diets impair secretion of hepatic
triglycerides as VLDLs. In the absence of dietary protein, de novo protein synthesis is inhibited.
In turn, this decreases VLDL production and transport resulting in increased hepatic lipid
accumulation (Kumar et al., 1972). In a more recent study, Zutphen et al. (2016) fed growing rats
low protein (5% kcal) diets to assess peroxisomal and mitochondrial dysfunction as a potential
underlying mechanism in malnutrition induced NAFLD. Results showed hepatic steatosis and
hypoalbuminemia was accompanied by reduced peroxisome number and mitochondria activity
which impaired hepatic ATP production through oxidation of fatty acids (Zutphen et al., 2016).
In contrast, high protein and low carbohydrate diets prevent hepatic fat deposition by stimulating
carbohydrate metabolism, DNL, and lipid transport (Kargulewicz et al., 2014).
Duarte et al. (2014) reported providing high protein and low carbohydrate diets to adults with
NAFLD reduced VLDL and low density lipoprotein (LDL) concentrations, enhanced high
density lipoprotein (HDL), and improved liver damage biomarkers. Additionally, protein source
has been shown to affect NAFLD progression. Kani et al. (2014) found providing NAFLD
patients a low calorie and low carbohydrate diets containing soy protein improved biomarkers of
liver damage, but lipid profiles were not affected. Similarly, soy protein supplementation
reduced plasma cholesterol and hepatic triglyceride deposition while enhancing insulin
sensitivity and antioxidant capacity in rats (Yang et al., 2011).

17

Given the limited number of studies, additional research is needed to determine the role
dietary protein amount and source on liver health and disease pathogenesis. This is important
because untreated NAFLD can progress to non-alcoholic steatohepatitis (NASH) indicated by
inflammation in as well as liver steatosis (Michelotti et al., 2013). It is estimated that 25% of the
world’s population has NAFLD with a quarter of those individuals having NASH (Diehl et al.,
2017). A multiple-hit model has been used to explain the progression of NAFLD, initiated by fat
accumulation in the liver followed by the onset of inflammation (Buzzetti et al., 2016). The
immune system is implicated in a variety of diseases, including those associated with poor diet.
Therefore, we will also introduce the major inflammatory markers pertaining to diet-induced
diseases.
6. Inflammatory Markers
Interleukin 10 (IL-10) and tumor necrosis factor alpha (TNF-α) are often referred to as “the
good” and “the ugly” cytokines, respectively (Stenvinkel et al., 2005). IL-10 is suggested to be
the most important anti-inflammatory cytokine with secretion typically followed by a
proinflammatory signal by a few hours (Stenvinkel et al., 2005). TNF-α is multifaceted with
roles in lipid metabolism, coagulation, insulin resistance, and endothelial dysfunction. However,
TNF-α is proposed to be the master regulator of cytokines (Stenvinkel et al., 2005). TNF- α and
the transcription factor, nuclear factor kappa-light enhancer of activated B cells (NFκB), are key
regulators in COX-2 expression. COX-2 catalyzes the conversion of arachidonic acid to proinflammatory prostaglandins that play a significant role to the pathology of several diseases (Lee
at al., 2015; Lim et al., 2001).
NAFLD has been shown to stimulate inflammatory gene expression, through activation of
transcription factor NFκB (Milanski et al., 2009). NFκB is involved in the activation of
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downstream inflammatory cytokines, such as interleukin 6 (IL-6) and TNF-α, resulting in
increased inflammation in the liver (Buzzetti et al., 2016; O’Neill et al., 1997). This
inflammatory cascade is not limited to the liver. The inflammatory process was also implicated
in adipose tissue. Lipogenesis resulting from alterations in fatty acid and glucose metabolism
result in changes in fatty acid profiles of stored lipids in adipose tissue and inflammation status.
This state can further exacerbate increased hepatic DNL in NAFLD patients (Musso et al., 2012;
Burhans et al., 2016; Tamura et al 2015). When mitochondria and peroxisomes are overloaded
by increased lipid production, lipid derived reactive oxygen species (ROS) are produced which
activate inflammatory pathways (Buzzetti et al., 2016). Cusi (2009) reported ROS, together with
oxidized lipoproteins, may activate Kupffer and hepatic stellate cells, which lead to additional
inflammation and fibrosis. Further, increased generation of reactive oxygen species and
inflammation from free fatty acid metabolism promotes NAFLD progression to more severe
NASH (Michelotti et al., 2013).
The relationship between protein malnutrition and NAFLD has not been well-studied. Protein
malnutrition has been shown to increase inflammatory reactivity that may contribute to
development of NAFLD and edema (Sauerwein et al., 1997). Plasma concentrations of mediators
of the inflammatory cascade were assessed in children identified with protein energy
malnutrition. Children with protein energy malnutrition exhibited greater (p<0.05) serum
concentrations of IL-6, C-reactive protein, and soluble receptors of tumor necrosis factor alpha
(sTNFR-p55 and sTNFR-p75). However, no significant differences were reported in serum IL-1
concentrations among patients with or without protein energy malnutrition. Further, serum
concentrations of antioxidants (glutathione and vitamin E) was used to assess antioxidant status.
Patients with protein energy malnutrition had lower (p<0.05) levels of circulating antioxidants.

19

Collectively, results from this study showed protein energy malnutrition increased inflammatory
and ROS reactivity in children suggesting enhanced inflammatory and oxidative stress may
contribute to NAFLD (Sauerwein et al., 1997). High protein diets rather than protein energy
malnutrition are common in developed countries. However, high protein consumption has been
implicated as a risk factor contributing to the increasing prevalence of childhood obesity in
Western countries.
7. Infant Nutrition and Protein
Cow-milk-based infant formula is widely used in developed countries as a substitute for
breastmilk when breastfeeding is not possible. Infant formulas often have higher protein content
compared to human breast milk of ~2.2 g/100 kcal and ~1.5 g/100 kcal, respectfully. This
discrepancy has been associated with weight gain in formula-fed infants and to obesity later-inlife (Tang, 2018). This “early protein hypothesis” suggests that a higher protein intake through
infant formulas increase circulating branch chain amino acids (leucine, isoleucine, and valine)
and other essential amino acids, which stimulate the secretion of insulin and insulin-like-growth
factor 1 (IGF-1) that promotes weight gain in formula-fed infants (Tang, 2018).
In a longitudinal study, formula-fed infants (n=1138) were randomly assigned to lower
protein (1.77 - 2.2 g protein/100 kcal) or high protein (2.9 - 4.4 g protein/100 kcal) groups for the
first two years of life (Koletzko et al., 2009). There was no significant differences in infant
length among the diet groups. However, infants consuming lower amounts of high-quality
protein had reduced risk of weight gain and later risk of obesity compared to infants fed a high
protein diet (Koletzko et al., 2009). Marsh et al. (2016) used health economic modeling to
predict the long-term economic outcomes of lower protein infant formulas compared to higher
protein formulas. The model predicted lower (p<0.05) lifelong body mass index and incidence of
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obesity in individuals fed low protein infant formula. Therefore, reduce healthcare costs and
improve population productivity were predicted for infants provided lower protein infant
formulas.
The effects of low protein intake during infancy on body composition and safety has not been
extensively assessed, raising safety concerns about adequate growth and maturation (Patro-Golab
et al., 2016). Therefore, protein sources with amino acids profiles containing all 10 essential
amino acids in high amounts to promote growth by stimulating maximal protein synthesis are
required.
8. Metabolism of Branched Chain Amino Acid
Branched chain amino acids (BCAAs) are composed of valine, leucine, and isoleucine.
BCAAs make up approximately 40% of the required essential amino acids in humans. Further,
the essential amino acids in muscle proteins are comprised of approximately 35% BCAA
(Harper et al., 1984). Circulating levels of BCAAs are highly regulated by systems with rapid
responses to excess or deficient conditions.
Figure 2 provides the pathway of BCAA catabolism. Skeletal muscle is considered a primary
site for BCAA catabolism due to high concentrations of branched chain aminotransferase
(BCAAAT) (O’Connell, 2013). BCAAAT catalyzes the reversible transamination of BCAAs
producing branched chain ketoacids (BCKAs) in the cytosol of cells. BCKAs are transported into
the mitochondria through the carnitine shuffle. In the mitochondria, BCAAs are degraded by
branched chain alpha-keto acid dehydragenase (BCAKADH), to produce BCKAs, that undergo
oxidative decarboxylation. Coenzyme A compounds are produced and further oxidized to form
acetyl CoA and succinyl CoA. These products then enter the citric acid cycle for use in energy
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production (O’Connell, 2013). However, proteins play a minor role in energy production in the
body.
Instead BCAA catabolism is important in the production of additional amino acids such as
glutamine and alanine. Glutamine serves as a bioenergetic substrate for cell growth and is found
in the highest amount of all amino acids circulating in blood (DeBerardinis et al., 2010).
Glutamate is the primary nitrogen donor in the synthesis of nonessential amino acids and is used
as a signaling molecule in the regulation of cell proliferation by supporting energy production by
entering the citric acid cycle. Additionally, glutamine can be converted to glutamate by the
removal of an amino group catalyzed by glutaminase when needed for energy production.
Alanine is utilization in protein synthesis, glucose production in the liver for gluconeogenesis
and participates in the glucose alanine cycle during starvation. Alanine produced from BCAAs is
transported to the liver for glucose production (O’Connell et al., 2013). Subsequently, dietary
protein and BCAAs act as signaling molecules to modulate energy metabolism to sustain
homeostasis within the body. Studies have reported increased secretion of insulin like growth
factor 1 (IGF-1) potentiates greater body weight gains in infants fed whey-based formulas high
in BCAAs (Ong et al.,2009). Therefore, the next section provides an overview of IGF-1.
9. IGF-1: Role & Signaling
IGF-1, secreted mainly from the liver, is considered a somatomedin that regulates animal
growth and metabolism by mediating growth hormone (Daughaday et al., 1989; Ohlsson et al.,
2009). Synthesis of IGF-1 is dependent on both nutritional status and concentrations of
circulating hormones, insulin and growth hormone. Serum IGF-1 concentrations are highly
regulated and mediated by IGF binding proteins family and acid-labile subunit (O’Connell et al.,
2013). Figure 3, illustrates the IGF-1 dependent pathway for upregulating anabolic metabolism
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through the activation of mammalian target of rapamycin complex 1 (mTORC1) (O’Connell et
al., 2013).
Phosphatidylinosotide 3-kinase and protein kinase B are activated by IGF-1 and insulin,
resulting in phosphorylation of tuberous sclerosis protein 2 (TSC2). This attenuates the inhibition
of the TSC1/TSC2 complex, activating the Ras homolog enriched in brain (Rheb) leading to the
final activation mTORC1. Three downstream transcription factors of mTORC1 are critical for
anabolism: ribosomal protein S6 kinase 1 (S6K1), SREBP, and eukaryotic translation initiation
factor 4E binding protein 1 (4EBP1). S6K1 and SREBP lead to synthesis of proteins and lipids,
respectively while 4EBP1 enhances mRNA translation and growth (O’Connell, 2013)
The role of amino acids in the induction of IGF-1 secretion has not been well-studied.
However, recently, Wan et al. (2017) provided pigs a normal protein diets (20% kcal protein) or
low protein diets (14% kcal protein) to determine the role of dietary protein has on IGF-1
expression, secretion, and subsequent hepatic transcriptome alterations. Serum IGF-1 and IGF-1
expression were greater (p<0.05) in pigs fed a normal protein diet compared to a low protein
diet. Additionally, RNA sequencing identified 1,319 genes that were differentially expressed
among the diet groups with pathway analysis reporting PPAR pathway to be among the
stimulated pathways.
IGF-1 expression was dependent on amino acid concentration and PPARγ in porcine primary
hepatocyte models. Dosing with greater amino acid concentrations resulted in upregulation (p <
0.05) of IGF-1 and PPARγ gene expression. Further, amino acid induced IGF-1 expression was
reversed by PPARγ knocked down in HepG2 cells. Collectively, results indicated PPARγ plays
an important role in IGF-1 response to dietary protein (Wan et al, 2017). Global gene expression
profiles of hepatic transcriptome have the potential to identify the effect of novel dietary protein
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on pathways and gene alterations. This is important given the central role of the liver in
toxicology as well as in many aspects of whole-body physiology.

10. Effect of Protein Source on Hepatic Transcriptome
Protein sources have been shown to have significant effects on metabolism. Meat and meat
products provide excellent sources of high-quality proteins, indicated by high biological values,
amino acid scores and digestibility, as well as content of micronutrients required for life-long
health (McNeill et al., 2012; Pereira et al., 2013). Fish protein has been suggested to improve
insulin sensitivity (Song et al, 2016). However, research on the effect protein source has on
physiological and gene-expression responses is limited.
Song and colleagues (2016) investigated the effect of dietary protein source on hepatic
transcriptome. Male rats (age 28 days) were fed adequate (18 % kcal) protein diets based on the
AIN-93G diet with protein sourced from beef, pork, chicken, fish (carp), and casein for 7 days.
Following 7 days of feeding, rats were euthanized, livers were dissected, and serum was
collected for serum biomarker assessment and amino acid profiling. Casein-fed rats were used as
the control for all analyses. Results showed total plasma amino acid concentrations were greater
(p<0.05) for all proteins except pork. However, pork protein reduced (p<0.05) adiposity and
hepatic triglycerides concentrations. Fish protein consumption attenuated serum total cholesterol.
Liver transcriptome response was also investigated. Results showed rats fed pork had the
lowest number of differentially expressed genes at 609 genes, while rats fed chicken had the
largest number of significantly expressed genes at 1258. Pathway analysis using conservative
significant thresholds (p<0.05; false discovery rate (FDR)<0.25) indicated transcriptome
response from rats consuming chicken and beef were comparable to casein. Interestingly, fish
consumption resulted in the greatest number of pathway response alterations. All meat proteins
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enhance expression of antigen production, intracellular trafficking, and oxidoreductivetransformation pathways while suppressing signal transduction and mitochondrial biogenesis.
Pork was the only protein source to suppress lipid and amino acid metabolic pathways while
both fish and beef protein sources induced amino acid transport. Additionally, fish consumption
was the only protein source that reduced nuclear-transport and cofactor metabolism.
Many of the observed differences were attributed to the difference in concentrations of
leucine among the protein diets. Leucine has been suggested to mediate the activation of
mTORC and its role in the activation of transcript factors involved in protein synthesis, lipid
biosynthesis, and cell growth (O’Connell, 2013). Collectively, study results suggested distinct
physiological, metabolism and gene expression responses can be implemented in rats fed diets
containing different protein sources. However, metabolism changes with age, gender, and dietary
protein content and sources. Song and colleagues (2016) investigated 18 % kcal protein diets
derived from carp muscle (sarcoplasmic and myofibrillar proteins). To our knowledge, no studies
have investigated the effects of a 10 % kcal protein diet derived from carp sarcoplasm protein on
global and hepatic gene expression.
In reviewing the literature, few studies have investigated the nutritional quality of aquatic
proteins compared to other commercial sources or specifically investigated in vivo safety and
effects on metabolism. Additionally, most studies focused on safety of high or normal protein
intake despite the prevalence of stunted growth and NAFLD due to protein energy malnutrition
in many countries. Further, in Western countries there is an initiative to lower protein content in
infant formulas to reduce risk of childhood obesity. This has led to research discoveries for a
cost-effective and sustainable source of high quality protein that adequately supports growth and
is safe when fed at lower levels.
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12. Figures and Tables

Figure 1: Diagram of de novo lipogenesis, lipid storage, and lipid transport pathways.
Adapted from Millar et al. (2013). Abbreviations: ACC, acetyl co-A carboxylase; ACL, ATP
citrate synthase; ApoB, apolipoprotein B; ChREBP, carbohydrate response element bind
protein; CPT-1, carnitine palmitoyltransferase 1; diacylglycerol O-acyltransferase 2; FAS,
fatty acid synthase; FFA, free fatty acids; HSL, hormone sensitive lipase; LCE, long chain
fatty acyl elongase; SCD, stearoyl-CoA desaturase; SREBP-1c; sterol regulatory element
binding protein-1c; VLDL, very low-density lipoprotein.
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Figure 2: Catabolism pathways for branched chain amino acids. Adapted from O’Connell et
al. (2013). Abbreviations: αKG, α-ketoglutarate; AcCoA, acetyl-CoA; Ala, alanine; ALT,
alanine aminotransferase; ASCT2, ASC-type amino acid transporters; BCAAAT, branched
chain amino acid aminotransferase; BCAADH, branched chain amino acid dehydrogenase;
BCKA, branched chain ketoacid; Citr, citrate; CS, carnitine shuttle; DCC, dicarboxylate
carrier; Glu, glutamate; GDH, glutamate dehydrogenase; GLS, glutaminase; Gln, glutamine;
GLNS, glutamine synthetase; LAT1, Large neutral amino acid transporter; Lac, lactate;
Leu, leucine; Mal, malate; NADP+; nicotinamide, adenine dinucleotide phosphate;
NADPH, reduced form of nicotinamide, adenine dinucleotide phosphate; Pyr, pyruvate;
TCC, tricarboxylate carrier.
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Figure 3: Illustration of branched chain amino acids and IGF-1 role in the activation of
mTORC1 and subsequent downstream pathways. Adapted from O’Connell et al., 2013.
Abbreviations: Akt, Protein Kinase B; AMP, adenosine monophosphate; AMPK, adenosine
monophosphate kinase; ATP, adenosine triphosphate; 4EBP1, eukaryotic translation
initiation factor 4E binding protein 1; GLUT, glucose transport protein; IGF-1, insulin-like
growth factor-1; IGF1R, IGF1 receptor; IR, insulin receptor; IRS-1, insulin receptor
substrate 1; mTORC1, mammalian target of rapamycin complex 1; PI3K,
phosphatidylinosotide 3-kinases; Rag GTPases, Rag guanine triphosphate hydrolysis
enzymes; Rheb, Ras homolog enriched in brain;; S6K1, ribosomal protein S6 kinase;
SREBP, sterol regulatory element-binding protein; TSC1/TSC2, complex of tuberous
sclerosis proteins 1 & 2.
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Chapter III
Study Objectives and Hypotheses
Study 1
Previous research investigated in vitro nutritional quality of a water-soluble protein powder
derived from silver carp. The results of this study indicated soluble proteins derived from silver
carp are nutrient rich and have functional properties; however, bioavailability, protein quality
and safety were not considered.
Objective: To evaluate the protein quality of carp sarcoplasm protein (CSP) powder and the
effects of low (10% kcal) protein diets on growth, body composition, renal markers, and bone
health during growth and development.
Hypothesis: Protein quality of CSP is expected to be comparable to popular commercially
available milk proteins, casein and whey protein isolate. Collectively, these results are expected
to contribute to fish sustainability by using an invasive fish species and by reducing the amount
of protein required to be consumed for protein synthesis without negative affecting renal and
bone health.
Study 2
Feeding growing rats diets consisting of 10% kcal protein as CSP showed no significant
differences in nutrition quality compared to casein and whey protein and was determined to be
safe. However, whey protein consumption enhanced adiposity.
Objective: To assess the effect of low protein (10 % kcal) diets consisting of CSP compared to
two common commercial protein powders (e.g. casein and whey) on lipid metabolism in liver
and adipose tissue compared to a protein deficient diet.
Hypothesis: CSP powder is expected to alter lipid metabolism resulting in reduced adiposity,
adipose tissue lipolysis, and hepatic lipid accumulation compared to casein and whey protein.
Study 3
There were few alterations in lipid metabolism in rats fed low protein (10% kcal) diets derived
from carp, casein, and whey protein. However, differences in amino acid profiles among
different protein sources may have altered amino acid catabolism and insulin like growth factor 1
(IGF-1) pathway activation. Additionally, greater hepatic lipid deposition was seen in rats fed a
protein deficient diet.
Objectives: To investigate distinct phenotypic and hepatic transcriptome responses due to low
protein (10% kcal) diets consisting of CSP and milk proteins, casein and whey, in a growing
animal model.
Hypothesis: CSP consumption is expected to result in no difference in transcriptome responses
compared to casein; whereas, increased branched chain amino acids in whey protein is expected
up regulate IGF-1 secretion and related pathways. Further, protein deficient rats are expected to
exhibit distinct transcript responses with upregulation of lipid synthesis and storage pathways
compared to the protein fed diet groups.
Overall Hypothesis: CSP is a high quality protein comparable to casein and whey protein.
Lowering dietary protein content using CSP as the high quality protein is expected to be safe
based on hepatic, renal, and bone health markers. Further, CSP may be preferable to whey
protein for preventing weight gain due to adiposity. Based on these characteristics, CSP provides
a sustainable alternative to current commercial protein powder.
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Abstract
Consisting of 25 – 30% of protein in carp, water-soluble sarcoplasmic proteins lost in wash
water, have been recovered and freeze-dried into a protein-rich powder. Study objectives were to
evaluate protein quality and safety of a silver carp sarcoplasm derived protein powder (CSP)
compared to commercial protein supplements, casein and whey. In vivo protein quality
assessment of CSP showed a lower (p<0.05) protein digestibility corrected amino acid score
compared to the commercial protein sources. Despite greater (p<0.05) fecal amino acid excretion
in casein fed rats, there were no significant differences in liver and muscle amino acid profiles.
All low (10% kcal) protein diets supported growth with the normal range. However, whey
protein supplementation resulted in greater (p<0.05) adiposity. CSP, casein, or whey-fed rats
showed no differences in major organ weights, renal damage biomarkers, or bone indices.
Collectively, results indicated CSP was safe with protein quality comparable to casein.
Keywords: Silver Carp, Sarcoplasm Protein, Protein Quality, Protein Safety, Amino Acid

Practical Application
As much as 40 percent of protein in fish can be lost due to sarcoplasmic protein solubilization in
processing wash water. Silver carp sarcoplasm protein powder may have similar commercial
potential as a sustainable and nutritious alternative to whey and casein proteins. This project
aimed to verify the protein quality and safety of this economical protein source.
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Introduction
Current fishery resources are operating either close to optimal yield or at levels with elevated
risk for fish stock depletion (FAO, 2016). In 2016, the Fishes and Aquaculture Organization
reported global aquaculture growth declined by 3.3% meanwhile the human population continues
to increase by 1.6%, annually with an expected global population of 10 billion by 2050. A
solution for overcoming limitations of sustainable natural fish resources is through utilization of
less desirable fish species and fish processing by-products. Silver carp (Hypophthalmichthys
molitrix) was imported to the United States in the 1970s for use as filter feeders in aquaculture.
Since their unintentional introduction into the wild, silver carp has become an invasive species
resulting in negative impacts on the food chain in North American freshwater river systems
(Chick, 2001).
Carp is composed of 7.13% fat, consisting mainly of the health beneficial long-chain omega3 polyunsaturated fatty acids (n-3 PUFAs) (Ljubojević et al., 2017), and 16.69% protein,
comprising all the essential amino acids required by adults and children (Skibniewska, 2013).
Silver carp’s abundance and nutritional composition makes it a sustainable fish species. Due to
its low commercial value as an edible fish in North American, carp may be processed into valueadded products such as surimi. In surimi manufacturing, myofibrilar (muscle) protein is
concentrated through repeated washes (Arvanitoyannis & Kassaveti, 2008). During the washing
steps in surimi manufacturing, the water-soluble sarcoplasmic protein comprised of 20 – 30 % of
fish protein, are lost in wash water disposal (Okada, 1999).
Previous research showed silver carp sarcoplasmic proteins in wash water can be recovered
and freeze-dried into a protein-rich powder (Warren et al., 2018). However, before carp
sarcoplasm protein (CSP) powder can be commercialized, the protein quality and safety of this
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novel protein supplement needs to be evaluated. A study by Wibowo et al. (2007) compared
sarcoplasm protein powder recovered from surimi wash water to casein and commercial protein
meals. Protein recovered from surimi wash water was determined to be higher in protein quality
than casein and commercial protein meals and considered safe based on an absence of significant
changes in blood chemistry measurements after feeding 18% kcal protein to rats aged 40 days for
20 days during the pubescent stage. Our study assessed the effects of lower (10% kcal) protein
diets on anabolic development of immature (28 day old) rats for 28 days. Reduced protein was
used to investigate whether lower protein content may reduce the risk of obesity and renal
damage.
An European multi-centered clinical study reported infants receiving a high protein formula
resulted in higher kidney volume compared to infants receiving a low protein formula or
breastfed infants. Higher kidney volume was attributed to increased renal workload indicated by
greater serum urea/creatinine ratios (Escribano et al., 2011). Infant formulas often have higher
protein content compared to human milk and this have been related to weight gain and obesity
later-in-life (Tang, 2018). In a longitudinal study, infants fed lower amounts of protein, but of
high-quality reduced risk of overweight or obesity (Koletzko et al., 2009). Marsh et al. (2016)
predicted lower lifelong body mass index and lower incidence of obesity in individuals who
received low protein infant formula. However, low protein intake during infancy effects on body
composition has not been accessed raising safety concerns about adequate growth and maturation
(Patro-Golab et al., 2016).
Therefore, the objectives of this study were to evaluate the protein quality of CSP and
effects of a lower (10% kcal) protein diets on growth, body composition, renal markers, and bone
health during growth and development. Weanling rats were used as a model for studying low
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protein diets from different sources during growth. We hypothesize sarcoplasm protein-derived
carp protein quality is comparable to popular commercially available milk proteins, casein and
whey protein isolate (WPI) and in turn, can contribute to sustainability by reducing amount of
protein consumed for protein synthesis.
2 Materials and Methods
2.1 Protein Powder Production
Headed and gutted silver carp were purchased from FIN Inc. (Kentucky, USA) and
shipped on ice through overnight mail to the West Virginia University Agricultural Sciences
Building. Upon delivery, carp was unpacked from ice, immediately twice course ground in a
meat grinder (Hobart, model # 4146 SS). Ground carp was portioned into vacuum-sealed bags
and stored at -80°C until processing. CSP powder was recovered according to methods
previously described by Warren and colleagues (2018). Briefly, thawed ground carp was mixed
with 1:3 deionized and distilled water (ddH2O) and homogenized on ice for 10 min using a
homogenizer (Omni International, model GLH, Kennesaw, GA USA) with a 45 mm probe
(Omni International, model GLH, Kennesaw, GA USA). The homogenized paste was
centrifuged (Sorvall, model 728211, Newtown, CT) at 10,000 × g for 15 min at 4°C and the
sarcoplasmic protein supernatant (i.e. wash water) was collected and filtered through
cheesecloth. Centrifugation was repeated on filtered supernatant, and additional supernatant was
collected then filtered. Total supernatant (i.e. wash water) was freeze-dried into a powder in a
freeze drier (VirTis, model #35L, SP Industries Inc., Warminster, PA USA). Purity of CSP was
verified with proximate composition and sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) in Warren et al. (2018). Proximate composition of the CSP powder
was determined according to the Association of Official Analytical Chemists (AOAC) methods
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(AOAC, 1995). Proximate composition and SDS-PAGE revealed CSP was 82% crude protein
with the majority consisting of low molecular weight sarcoplasmic proteins (Warren et al.,
2018).
2.2 Research and Development
Amino acid analysis on the CSP powder was conducted at the University of MissouriColumbia according to the AOAC method 982.30 E (AOAC, 1995). Briefly, samples were
hydrolyzed with 6 N hydrochloric acid at 110 °C for 24 hr. The samples were further oxidized by
performic acid overnight at 0-5°C. Acid hydrolysis was repeated as described followed by a final
alkaline hydrolysis with 4.2 N NaOH at 110°C for 22 hr. A Beckman amino acid analyzer
(model 6300, Beckman Coulter, Fullerton, Calif., USA) was used to determine the amino acid
profile of the hydrolyzed samples using sodium citrate buffers in step gradients with a cation
exchange post-column ninhydrin derivation method. Amino acid composition of CSP, casein,
and WPI is provided in Table 1. The CSP powder was vacuum-sealed and stored at -80 °C until
used for rodent diet formulation.
2.3 Diets
The American Institute of Nutrition-93G (AIN-93G), a standard purified diet that meets
all the nutrient requirements for growing rats as defined by the National Research Council (1995)
was used during the acclimation period. For treatment diets, AIN-93G diet was modified from 20
% kcal protein to contain 10% kcal protein consisting of either CSP, casein or WPI. Diet
ingredients and composition are provided in Table 1. All treatment diets were formulated to be
isocaloric with the only difference being the protein source. All diets as well as casein and WPI
were purchased from Envigo-Teklad (Madison, WI).
2.4 Animal Feeding Study
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The rodent feeding study was approved by the Animal Care and Use Committee (ACUC)
at West Virginia University (WVU) (ACUC Protocol # 1603000861) and followed the
guidelines set forth by the National Research Council for the Care of Laboratory Animals
(2010). Immature (age 28 d) female Sprague-Dawley rats were purchased from Charles River
(Worcester, MA). Upon arrival, rats were individually housed in metabolic cages throughout the
study to collect urine and feces. Rats were maintained in room at 21°C with a 12h light/dark
cycle.
Rats were fed the purified AIN-93G diet during acclimation for 7 days. Following
acclimation, rats were housed in metabolic cages and randomly assigned (n=8 rats/group) to one
of four experimental diet groups: (1) AIN-93G with 10% kcal CSP for 4 weeks, (2) AIN-93G
with 10% kcal casein for 4 weeks, (3) AIN-93G with 10% kcal WPI for 4 weeks or, (4) AIN93G with 10% kcal casein for 2 weeks followed by protein free diet for the remaining 2 weeks to
assess endogenous protein loss. Rats were fed 16.0 ± 0.2 g of their assigned diet daily throughout
the study duration.
Food intake was recorded then replaced with fresh diet daily. Methods as described by
Gigliotti et al. (2008) were used to calculate feed consumption. Rats were provided deionized,
distilled water ad libitum. Intake of ddH2O was measured weekly by recording pre- and postbottle weights and amount spilled. Urinary and fecal samples were collected weekly. A screen in
the metabolism cages separated feces and urine. Ascorbic acid (0.1%) was added to the urine
collection tube as a preservative with 1 ml of mineral oil added to prevent evaporation. Body
weight was recorded weekly. Following 4 weeks of feeding, animals were fasted for 12 h and
euthanized by carbon dioxide inhalation according to the WVU ACUC approved protocol.
2.5 Protein Quality Measurements
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Protein quality measurements included: true digestibility (D), true biological value (BV),
net protein utilization (NPU), amino acid score (AAS), protein digestion corrected for amino
acid score (PDCAAS) and relative protein efficiency ratio (PER). Relative PER values were
adjusted to the standardized 2.5 value for the casein reference. Protein quality measurements
were calculated according to the FAO (1990) where I is nitrogen intake, FN is fecal nitrogen
excreted, EFN is endogenous fecal nitrogen, UN is urinary nitrogen excreted, and EUN is
endogenous urinary nitrogen excreted using the formulas below:
True Digestibility (D) = [I – (FN – EFN)) / I]
True Biological Value (BV) = [I – (FN – EFN) – (UN – EUN]/ (I – (FN – EFN)]
Net Protein Utilization (NPU) = [I – (FN – EFN) - (UN – EUN)]/ I
Amino Acid Score (AAS) = (amount of limiting amino acid in the test protein /measured
amount of limiting amino acid in reference protein)
Protein Digestibility Corrected for Amino Acid Score (PDCAAS) = (AAS) x D
Relative Protein Efficiency Ratio (PER) = Body Weight / (I*6.25)

Collected urine samples were centrifuged at 1500 x g for 10 min at 4oC then aliquoted
into fresh tubes and stored at -20°C until assayed for nitrogen content. Fecal samples were
freeze-dried for 48 h then stored at -20°C until assayed for crude nitrogen content. Nitrogen
measurements were obtained using the Kjeldahl method (AOAC, 1995).
2.6 Biological Sample Amino Acid Analysis
Amino acid profiling was performed on hepatic tissue, gastrocnemius muscle, and fecal
samples collected during the final week. Biological samples were freeze-dried (VirTis, model
#35L, SP Industries Inc., Warminster, PA USA). After drying, 15 mg of each biological sample
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was hydrolyzed with 6N HCl in evacuated sealed tubes at 99°C for 24 h. Amino acids from
hydrolyzed biological samples were isolated and derivatized using the Easy-Fast Amino Acid
Sample Testing kit (Phenomenex, Torrance, CA). Amino acids were quantified using a gas
chromatograph (GC) (6890N, Agilent Technologies, Santa Clara, CA, USA) coupled to a mass
spectrometry (MS) detector (5975B, Agilent Technologies, Santa Clara, CA, USA) equipped
with an autosampler (7683B, Agilent Technologies, Santa Clara, CA, USA).
Hepatic, gastrocnemius muscle, and fecal samples were dried and sent to the University
of Missouri-Columbia for cysteine, methionine, and tryptophan verification. Cysteine and
methionine analysis were conducted according to the AOAC official method 994.12 with
performic acid oxidation (AOAC, 1995). While tryptophan analysis was conducted according to
the AOAC official method 988.15 with alkaline hydrolysis (AOAC, 1995).
2.7 Organ Weights and Renal Function Measurements
Immediately following euthanasia by carbon dioxide inhalation, kidneys and other major
organs (i.e. brain, heart, liver, lungs) as well as spleen and thymus were dissected, trimmed,
blotted dry, and weighed as indicators of toxicity. The adrenals were weighed as indicators of
chronic stress. Retroperitoneal and gonadal fat pads were also excised and weighed. Collected
organs and adipose tissue were flash frozen in liquid nitrogen and stored at -80°C.
Blood was collected by cardiac puncture and centrifuged at 1500 × g at 4°C for 10 min.
Serum was collected and stored at -80°C until analyzed. Renal function was assessed by
measuring serum blood urea nitrogen (BUN), creatinine, total protein, albumin, calcium (Ca) and
phosphorus (P) by enzymatic colorimetric assays using a commercially available Vet- 16 rotor.
Absorbance was measured at 595 nm by Hemagen Analyst automated spectrophotometer
(Hemagen Diagnostics Inc., Columbia, MD).
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Determination of urinary calcium (Ca) excretion and kidney Ca content was conducted
according to methods described by Gigliotti and colleagues (2010). Briefly, right kidneys were
dried overnight in an oven then ashed in a muffle furnace (Lindberg 515A2, Watertown, WI) for
24 h at 550°C. Ashed kidneys were dissolved in 70% nitric acid (1 mL). Acidified samples were
diluted with 5 mL of ddH2O, filtered through Whatman no. 1 paper then diluted (1:50 v/v) to
volume with ddH2O. Urine was diluted (1:10 v/v) to volume with ddH2O. Kidney and urinary Ca
content was measured using inductively coupled plasma optical emission spectroscopy (model
P400, Perkin-Elmer, Shelton, CN).
2.8 Bone Measurements
Left and right femurs were dissected, defleshed, wrapped in saline soaked gauze, and
stored at -20°C until assayed. Bone morphometry measurements of medial lateral width, anterior
posterior width, and length were determined using a Vernier caliper (Bel-Art Products,
Pequannock, NJ). Length was measured from the medial condyle to greater trochanter. Bones
were dried at 110°C for 24 h then weighed using an analytical balance (Mettler Toledo,
Columbus, OH). Morphometry measurements were averaged for bone pairs (i.e. right and left)
after no bilateral differences were determined using paired t-test with significance level set at
p<0.05.
Bone strength indices were assessed using a TA.XT2i Texture Analyzer (Texture
Technologis Corp, NY) equipped with a three-point bending apparatus. The femora were placed
on supports (1 mm width at tip for femur) and force applied on the medial surface of the bones
by lowering a centrally placed blade (1 mm width) at a constant crosshead speed (0.1 mm/sec)
until the bone was broken. The load cell was 50 kg. The load-deflection data were collected by
PC interfaced with the TA.XT2i Texture Analyzer. Sample test distance was set at 10 mm with a
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signal collection rate of 100 points per sec. A force-displacement curve generated from the
biomechanical test was used to determine bone strength measurements. Peak force was measured
as the highest load obtained before bone fracture occurs. Ultimate stiffness was measured as the
slope of the curve responding to bone stiffness (Skinner et al., 2019). Ultimate bending stress is a
normalized calculated force that take into account the size of the bone while Young’s Modulus is
a normalized calculated bone stiffness taking into account bone size (Skinner et al., 2019).
Total mineral content was determined as described by Skinner et al. (2019). Briefly,
bones were ashed in a muffle furnace (Lindberg 515A2, Watertown, WI) for 24 h at 600°C and
then weighing ash. To determine bone Ca and P content, ashed femurs were dissolved in 70%
nitric acid (1 mL). Acidified samples were diluted with 5 mL of ddH2O, gravity filtered through
Whatman no. 1 paper then diluted (1:50 v/v) to volume with ddH2O. Bone Ca and phosphorus
concentrations were measured using inductively coupled plasma optical emission spectroscopy
(model P400, Perkin-Elmer, Shelton, CN).
2.9 Statistical Analysis
A completely randomized design was used in the animal feeding study with n = 8 rats per
experimental diet group. Results are expressed as mean ± standard error of the mean. One-way
ANOVA was used to determine differences among diet treatment groups. Post-hoc multiple
comparison tests were performed using Tukey’s test with treatment differences considered
significant at p<0.05 and tendency at p=0.08. All statistical analyses were performed using JMP
12.2 statistical software package (SAS Institute, Cary, NC).
3 Results and Discussion
3.1 Protein Quality Assessments
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Lowering the protein content of infant formula has been suggested to reduce risk for
developing overweight and obesity in children (Koletzko et al., 2009). When the quantity of
dietary protein is reduced protein quality and digestibility becomes more important for sustaining
growth. In our study, protein true digestibility showed no significant differences between CSP,
casein, and WPI. On the other hand, protein quality measurements of biological value (BV) and
net protein utilization (NPU) were higher (p<0.05) for CSP compared to WPI, but not casein
(Table 2). These measurements indicate rats consuming CSP and casein retained more nitrogen
compared to rats consuming WPI. This may be the result of casein being a ‘slow’ digested
protein due to coagulation in the stomach providing a sustained release of amino acids into the
blood for better nitrogen retention and utilization by the body (Boirie et al., 1997). Based on
comparable nitrogen retention to casein, CSP may also be a ‘slow’ protein.
PDCAAS is used to calculate protein % Daily Value on the Nutrition Facts Label and is
the routine method of estimating protein quality (Schaafsma, 2000; FOA, 1990). PDCAAS for
CSP was lower (p< 0.05) than both milk proteins, with casein having the highest PDCAAS
(p<0.05) (Table 2). Based on dietary amino acid analysis (Table 1), Phenylalanine + Tyrosine
was the limiting essential amino acid in CSP at 64.74 ± 0.65 mg/g protein, resulting in an amino
acid score of 0.61 and subsequently the lowest (p < 0.05) PDCAAS (0.57 ± 0.01). EAA content
was higher for whey compared to casein, with the exception of valine and histidine. PDCAAS
for WPI (0.63 ± 0.01) using histidine as the limiting amino acid was low compared to the
reported value of 1 for WPI (Hoffman & Falvo, 2004). However, PDCAAS does not take into
consideration the individual amino acids are digested with different efficiencies (Mathai et al.,
2017). PDCAAS was adopted as a routine assay for protein quality evaluation because it is rapid;
however, it often shows discrepancies compared to PER (Schaafsma, 2000). The protein quality
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calculation used in the development of infant formulas is PER since this calculation measures a
protein’s ability to support anabolic functions (Gropper, Smith, & Groff, 2005). In the current
study, there were no significant differences in relative and adjusted PER values among CSP,
casein, and WPI diet groups (Table 2). Similarly, Gigliotti and colleagues (2008) measured
protein quality of protein recovered from krill, another aquatic protein source, reported no
significant difference in PER compared to casein protein. WPI was not included in the Gigliotti
et al. (2008) study. Wibowo et al. (2007) reported a greater (p<0.05) PER for water-soluble
protein extracted from surimi wash water when compared to casein after correcting for lower
methionine content. Collectively, the protein quality measurements suggest CSP was comparable
to casein and WPI for digestibility, supporting growth, and most protein quality measurements.
3.2 Fecal and Tissue Amino Acid Profiles
Of the protein sources, casein-fed rats had the highest (p<0.05) fecal excretion of the
essential amino acid valine, as well as non-essential amino acids: alanine, serine, and glutamic
acid (Table 3). This may be attributed to higher content of these amino acids in the casein diet
with the exception of alanine. This may be because alanine is also used in the urea cycle and
excreted as urinary urea. In a study using growing pigs, animals fed a low protein diet reduced
nitrogen loss by restricting portal vein transport of alanine to the liver since alanine is a primary
nitrogen source for urea production (Wu et al., 2018). In the present study, liver content of
ornithine, an intermediate in the urea cycle, showed no significant differences among rats
consuming casein, CSP, and WPI.
Rats fed a protein-free diet for 2 weeks significantly lowered liver content of essential
amino acids: leucine, methionine + cysteine, phenylalanine + tyrosine, lysine, and histidine
compared to rats fed CSP and casein. Lower hepatic essential amino acid content may be due to
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their use for synthesis of non-essential amino acids since almost all essential amino acid
catabolic enzymes are found in the liver (Rao, 2002). Of the non-essential amino acids, only liver
tyrosine content was lower in rats consuming the protein-free compared to CSP diet; whereas,
liver content of alanine, proline, aspartic acid, and tyrosine was lower in in rats consuming the
protein-free compared to casein diet (Table 3). However, feeding rats low protein diets as either
CSP, casein, or WPI showed no significant differences in amino acid profile in the liver (Table
3). Collectively, fecal and tissue amino acid profiling results indicated among the different
protein sources, casein consumption resulted in the lowest nitrogen loss and highest hepatic
amino acid retention.
Further, there were no significant differences in muscle weights (Table 4) or
gastrocnemius muscle amino acid profile (Table 3) among rat fed CSP, casein, and WPI.
Interestingly, rats fed a protein-free diet for 2 weeks also showed no significant differences in
gastrocnemius muscle amino acid profile despite lower gastrocnemius muscle weight compared
to rats fed low (10% kcal) protein diet. This may be due to the ability of numerous transaminases
and deaminase in the liver to synthesize different amino acids to adjust amino acid imbalances in
the blood and peripheral tissues such as the muscles (Ritskes-Hoitinga et al., 1989).
3.3 Growth
Protein energy malnutrition has been characterized by stunted growth and fatty liver
(Zutphen et al., 2016; Waterlow, 1992). Growth rate can be influenced by the amount of protein
intake and the type of amino acid. Further, high quality proteins can contribute to sustainability
by reducing amount of protein consumed for protein synthesis. Lowering protein content of
infant formula has been suggested to have minimal effects on short term growth outcomes
(Timby et al., 2014). Supplementation of CSP and casein promoted comparable growth indicated
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by no significant differences in body weights throughout the 4 weeks study. On the other hand,
rats fed WPI had the highest (p<0.05) body weight starting at 2 weeks (Figure 1). Rats
consuming WPI showed no significant differences in gastrocnemius and soleus muscles weights
compared to rats consuming CSP and casein (Table 4). There were no significant differences in
retroperitoneal adipose among protein-fed groups. However, rats fed WPI had significantly
higher gonadal adipose weight compared to rats fed CSP (Table 4). Higher gonadal adipose
weight in rats fed WPI may be due to greater feed efficiency than rats fed CSP (Table 2).
Additionally, dietary amino acid analysis showed WPI contained more dietary leucine and
isoleucine (Table 1). Branch chain amino acids (BCAA): leucine, isoleucine and valine not only
act as substrates for protein synthesis and synthesis of nitrogenous compounds, but as signaling
molecules regulating glucose and lipid metabolism (Nie et al., 2018). Melnik (2012) reported
BCAAs are physiological stimuli of insulin and insulin like growth factor-1 (IGF-1) which
stimulates adipogenesis. Collectively, results suggest high consumption of BCAAs may promote
adiposity.
In our study, feeding a low (10% kcal) protein diets as CSP, casein or WPI supported rat
growth within the normal range according to body growth chart for female Sprague-Dawley
provided by the animal vendor (Charles River, Worcester, MA). Additionally, measurement of
major organ weights as well as spleen and thymus as an indicator of toxicity showed no
significant differences for rats fed CSP, casein, and WPI; whereas, feeding a protein-free diet for
2 weeks resulted in lower weight of spleen, thymus, and all major organs except for the brain
(Table 4). Koletzko et al. (2009) reported infants fed formulas with lower amounts of higher
quality protein resulted in lower body weight with no effects on infant growth. The authors
suggested consumption of high-quality proteins at lower levels may reduce risk of obesity later
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in life. Based on our study results, CSP supported comparable growth to casein while WPI
increased gonadal adipose compare to CSP. Therefore, CSP may be suitable for supporting
growth of lean body mass in lower protein infant formulas.
3.4 Evaluation of Kidney Health
Another consideration for decreasing protein content in infant formulas is based on
reports of greater kidney size and workload in infants receiving a high versus low protein
formula (Escribano et al., 2011). In our study, there were no significant differences in kidney
weights among protein-fed groups. Rats fed a protein-free diet for 2 weeks had lower kidney
weights (Table 4), but this was no longer significant after correcting for their smaller body size
(Supplemental Table 1). Diet is a major factor influencing urinary Ca excretion which promotes
hypercalciuria and can lead to nephrocalcinosis (Khan, 2010). A randomized study including
1,090 healthy term infants from five different countries reported hypercalciuria prevalence in
16.8% of infants fed a high protein formula (2.05-3.20 g/100mL) compared to 4.9% of infants
fed a low protein formula (1.25-1.60 g/100 mL) for 3 months (Ferre et al., 2017).
Wibowo et al. (2007) reported 18% kcal sarcoplasm protein powder was safe based on
serum measurements of kidney function using male rats. However, diet-induced nephrocalcinosis
is a more common occurrence in female rats (Rao, 2002). The transition of nephrocalcinosis to
nephrolithiasis has been implicated in nephropathy and subsequent renal failure in rats (Jara et
al., 2004). Zhang and Beynan (1992) reported feeding a 18% kcal protein diet resulted in greater
renal Ca deposition in rats fed a casein diet compared to cod meal. Gigliotti and colleagues
(2010) reported greater kidney weights and renal Ca deposition indicative of nephrocalcinosis in
female rats fed 10% kcal as casein compared to krill protein concentrate. In the present study,
despite higher Ca content in casein and CSP diet compared to WPI diet (Table 1) there were no
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significant differences in urinary Ca excretion among diet groups (Table 5). There were also no
significant differences in histological evidence of Ca deposits in renal intratubular or interstitial
parenchyma (data not shown) or kidney total Ca content among protein-fed rats (Table 5).
Further, there were no significant differences in any serum markers of renal function among rats
fed CSP, casein or WPI (Table 5). However, another safety concern is ensuring adequate protein
during the growth stage for bone health.
3.5 Evaluation of Bone Health
Kerstetter and colleagues (2003) reported low dietary protein intake correlated with
reduced bone density and increased rates of bone loss. Reduced bone density and structure
during growth and development increases risk of osteoporosis in adulthood (Gordon et al., 2017).
In the current study, the importance of adequate protein for bone was indicated by reduced
(p<0.05) femur longitudinal growth, bone size, and lower total bone mineral content (BMC) in
rats fed a protein-free diet (Table 5). Among rats fed different sources of protein, there were no
significant differences (p<0.05) in femoral longitudinal growth, bone size, total BMC, or Ca and
P content (Table 5). Similarly, Gigliotti and colleagues (2010) showed no significant differences
in femoral total bone mineral content, Ca, P between rats fed 10% kcal krill protein concentrate
compared to casein.
Chronic low protein diets have been associated with reduced bone mineral density and
increased risk of fracture (Kerstetter et al., 2003). In our study there were no significant
differences among dietary protein groups in any femur biomechanical strength measurements
(Table 5). Similarly, rats fed 10% krill protein concentrate and casein showed no differences in
bone strength (Gigliotti et al., 2010). In our study, absence of adverse bone effects in the proteinfree group may be because two weeks on a protein-free diet may not be a sufficient duration to
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reduce bone strength. There also may have been a bone protective effect with adequate mineral
intake provided in the diets. Ca and P are critical for formation of hydroxyapatite which provide
mechanical resistance of the organic bone matrix (Bonjour, 2011). Fournier et al., (2014) found
growing Sprague-Dawley female rats consuming a Ca (0.2%) and P (0.16%) diet for eight weeks
attenuated the low protein (5% casein) diet-related reduction in bone mass and strength.
Collectively, the bone results in the current study showed CSP was as safe as casein and WPI.
Conclusion
The study results indicated protein quality of CSP powder was comparable to standard
reference and popular commercially available, casein and WPI. There were no significant
differences in liver or muscle amino acid profile among protein protein-fed rats despite higher
fecal amino acid excretion in casein-fed rats due to body’s compensatory amino acid balance
mechanisms. Importantly, feeding low (10% kcal) protein diets supported rat growth within the
normal range. Additionally, CSP or casein may be better sources for lowering the protein in
infant formula to prevent obesity since WPI showed greater gonadal adipose weight. Safety was
indicated by rats fed CSP, casein or WPI having higher major organ weights, lymphatic tissue
weights compared to rats fed a protein-free diet. There were no significant differences in renal
function biomarkers or bone indices. Collectively, the animal study results indicated CSP derived
from fish processing waste water provides a high quality that may contribute to sustainability by
reducing amount of protein consumed to support adequate body and organ growth. Therefore,
CSP merits further investigation in human studies as a novel sustainable protein source for
potential commercialization.
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Table 1: Amino acid and nutritional composition of different protein sources and ingredient
formulation of experimental protein diets.
CSP
Casein* WPI*
No-Protein*
Component (%)
Moisture
6.86
11.1
4.7
Protein
75.64
85.5
93.9
Lipid
2.77
0.6
0.3
Ash
15.8
2.8
1.5
Essential Amino Acid (mg/g protein)
Valine
47.21 ± 0.18 70
56
Leucine
62.96 ± 0.26 94
143
Isoleucine
38.23 ± 0.14 58
63
Threonine
32.13 ± 0.21 44
53
Methionine + Cysteine
26.35 ± 0.27 31
64
Phenylalanine + Tyrosine
64.74 ± 0.65 105
80
Lysine
74.46 ± 0.44 82
112
Histidine
43.62 ± 0.24 29
20
Tryptophan
11.49 ± 0.16 12
24
Arginine
37.72 ± 0.21 39
30
Total Essential Amino Acid 438.91
506
563
Non-essential amino acids (mg/g protein)
Alanine
48.86 ± 0.22 32
57
Glycine
51.07 ± 0.27 19
18
Serine
28.17 ± 0.28 56
45
Proline
23.31 ± 1.05 84
45
Aspartic Acid
81.58 ± 0.42 71
125
Glutamic Acid
83.74 ± 0.48 229
176
Tyrosine
23.21 ± 0.18 54
42
Cysteine
9.88 ± 0.03
4
40
Taurine
25.98 ± 0.45 ND
ND
Total NEAA
375.8
549
548
Minerals (mg/g)
Calcium
295**
200
76
Phosphorus
2188**
8000
ND
Sodium
818**
<100
560
Magnesium
188**
<200
ND
Selected Nutrient Information*
Protein (%)
10
10
10.3
0
Carbohydrate (%)
66.9
67.8
68.1
78.1
Fat (%)
7
7.1
7
7
Energy (kcal/g)
3.7
3.8
3.8
3.8
Ingredient (g/kg)*
Whey Protein Isolate
111
Casein
115
Carp Protein
131.5
Corn Starch
482.236
492.036 495.286 605.986
65

Maltodextrin
132
Sucrose
100
Soybean Oil
66.5
Cellulose
50
Mineral Mix
13.4
Calcium Phosphate
0.75
Calcium Carbonate
11.1
Vitamin Mix
10
Choline Bitartate
2.5
TBHQ***
0.014
ND; no data
*Received from Envigo-Teklad (Madison, WI)
**Based on Warren et al., 2018.
***Tertiary butylhydroquinone
Values are mean ± SEM with n = 3 samples/group.

132
100
70
50
13.4
9.8
5.25
10
2.5
0.014

132
100
70
50
13.4
13.2
2.6
10
2.5
0.014

132
100
70
50
13.4
13.4
2.7
10
2.5
0.014
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Table 2: Protein quality and growth of female rats fed 10% protein diets consisting of casein, whey protein isolate, carp sarcoplasmic
protein, or 2 weeks on 10% casein diet followed by a no-protein diet.
CSP
Casein
WPI
No-Protein
Protein Quality Measure
True Digestibility (%)
94.43 ± 1.15
91.33 ± 2.37
94.03 ± 1.06
a
a
b
Biological Value
0.75 ± 0.04
0.73 ± 0.02
0.61 ± 0.04
Net Protein Utilization (%)
71.32 ± 3.99a
66.78 ± 1.88a
52.99 ± 4.83b
*
*
Amino Acid Score
0.61
1
0.68
PDCAAS
0.57 ± 0.01c
0.91 ± 0.02a
0.63 ± 0.01b
Relative Protein Efficiency Ratio (g body wt/g protein)
1.66 ± 0.06
1.87 ± 0.08
1.81 ± 0.11
Adjusted Protein Efficiency Ratio
2.22
2.5
2.43
Fecal Nitrogen Excretion (mg/day)
20.57 ± 2.50 ab
30.33 ± 3.92 a
30.36 ± 6.07 a
8.41 ± 0.98 b
Urinary Nitrogen Excretion (mg/day)
60.81 ± 7.03 b
58.36 ± 3.97 b
91.10 ± 8.37 a
10.61 ± 1.72 c
Growth Parameters
Total diet intake (g/4 weeks)
449.98 ± 3.13a
441.65 ± 6.99a
460.49 ± 1.79a
380.59 ± 11.52b
b
ab
a
Feed efficiency (g body wt/g diet intake)
0.16 ± 0.004
0.19 ± 0.009
0.20 ± 0.006
0.04 ± 0.007c
Final Body weight (g)
202.85 ± 3.33b
207.26 ± 2.89b
219.66 ± 2.66a
141.70 ± 2.98c
b
ab
a
Total body weight gain (g/4 week)
73.93 ± 1.71
82.68 ± 4.04
93.69 ± 3.11
15.82 ± 2.75c
*Phenylalanine + Tyrosine is the first limiting amino acid of CSP; Histidine is the first limiting amino acid for WPI
True Digestibility (D) = [I – (FN – EFN)] / I]; True Biological Value (BV) = [I – (FN – EFN) – (UN – EUN)]/ [I – (FN – EFN)]; Net
Protein Utilization (NPU) = [I – (FN – EFN) - (UN – EUN)]/ I; Amino Acid Score = (amount of limiting amino acid in the test
protein /measured amount of limiting amino acid in reference protein); Protein Digestion Corrected for Amino Acid Score (PDCAAS)
= Amino Acid Score x True Digestibility; Relative Protein Efficiency Ratio (PER) = Body Weight / (I*6.25); Corrected PER = PER ×
1.34.
Values are mean ± SEM of n = 8 rats/group. Different superscript letters a and b within the same row indicate significant difference at
p<0.05 by One-way ANOVA followed by Tukey’s test
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Table 3. Fecal, hepatic, and skeletal muscle amino acid profile of female rats fed 10% protein diets consisting of carp sarcoplasmic
protein, casein, whey protein isolate, or 2 weeks on 10% casein diet followed by a no-protein diet.
Feces
Liver
Gastrocnemius Muscle
Amino acids
CSP
Casein WPI
NoCSP Casein WPI
NoCSP Casein WPI
No(mg/g sample)
Protein
Protei
Protein
n
Essential amino
acids
Valine
0.40 ± 0.56 ± 0.39 ± 0.32 ± 3.03 ± 3.16 ± 2.67 ± 2.37 ± 2.60 ± 2.67 ± 2.82 ±
2.57 ±
b
a
b
b
0.03
0.03
0.03
0.02
0.14
0.13
0.21
0.30
0.29
0.29
0.28
0.23
Leucine
0.55 ±
0.7 ±
0.58 ± 0.47 ± 6.95 ± 7.22 ± 6.05 ± 5.27 ± 7.26 ± 7.51 ± 7.94 ±
7.50 ±
0.05ab
0.01a
0.04ab
0.03b
0.28a
0.26a
0.49ab
0.56b
0.42
0.27
0.18
0.26
Isoleucine
ND
ND
ND
ND
1.79 ± 1.87 ± 1.66 ± 1.52 ± 2.08 ± 2.32 ± 2.28 ±
2.20 ±
0.08
0.08
0.13
0.20
0.24
0.30
0.29
0.23
Threonine
0.39 ± 0.46 ± 0.42 ± 0.32 ± 3.04 ± 3.26 ± 2.78 ± 2.41 ± 3.30 ± 3.03 ± 3.38 ±
3.02 ±
0.05ab
0.3a
0.03ab
0.02b
0.15
0.12
0.26
0.31
0.40
0.31
0.35
0.31
Methionine +
0.45 ± 0.50 ± 0.44 ± 0.45 ± 2.14 ± 2.22 ± 1.94 ± 1.59 ± 3.28 ± 3.00 ± 3.04 ±
2.93 ±
Cysteine
0.04
0.04
0.03
0.04
0.06ab
0.09a
0.17ab
0.22b
0.06
0.22
0.18
0.18
Phenylalanine +
0.25 ± 0.28 ± 0.25 ± 0.22 ± 7.56 ± 7.88 ± 6.58 ± 5.35 ± 8.20 ± 7.10 ± 8.23 ±
5.36 ±
Tyrosine
0.02
0.02
0.02
0.02
0.20a
0.17a
0.42ab
0.46b
0.53
1.11
1.00
1.09
Lysine
0.41 ± 0.54 ± 0.16 ± 0.19 ± 4.74 ± 5.28 ± 3.99 ± 3.03 ± 6.23 ± 6.75 ± 7.27 ±
6.33 ±
0.19
0.15
0.07
0.12
0.44a
0.29a
0.43ab
0.49b
0.93
0.84
0.87
0.70
Histidine
0.25 ± 0.31 ± 0.24 ± 0.22 ± 3.45 ± 3.47 ± 2.79 ± 2.28 ± 3.66 ± 4.59 ± 4.18 ±
3.96 ±
0.01 ab
0.02a
0.01ab
0.01b
0.25a
0.19a
0.27ab
0.33b
0.31
0.40
0.31
0.39
Tryptophan
0.05 ± 0.06 ± 0.04 ± 0.05 ± 0.31 ± 0.55 ± 0.42 ± 0.66 ± 0.95 ± 0.91 ± 0.94 ±
0.92 ±
0.01
0.01
0.01
0.01
0.06b 0.09ab 0.04ab
0.04b
0.03
0.06
0.02
0.01
Non-essential
amino acids
Alanine
0.47 ± 0.64 ± 0.46 ± 0.41 ± 4.67 ± 4.92 ± 4.06 ± 3.65 ± 5.33 ± 5.40 ± 5.53 ±
5.12 ±
b
a
b
b
ab
a
ab
b
0.05
0.04
0.04
0.02
0.19
0.17
0.34
0.40
0.49
0.38
0.49
0.29
Glycine
0.37 ± 0.45 ± 0.41 ± 0.38 ± 3.68 ± 3.95 ± 3.24 ± 3.07 ± 5.50 ± 6.69 ± 5.49 ±
5.51 ±
0.03
0.013
0.017
0.037
0.10
0.08
0.28
0.37
0.33
0.86
0.58
0.39
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Serine
Proline
Aspartic acid
Glutamic acid
Tyrosine

Cysteine
Ornithine

0.44 ±
0.06b
0.49 ±
0.05ab
0.87 ±
0.13
0.89 ±
0.13b
0.25 ±
0.02

0.89 ±
0.04a
0.61 ±
0.02a
0.97 ±
0.11
1.56 ±
0.20a
0.28 ±
0.02

0.47 ±
0.04b
0.50 ±
0.03ab
0.80 ±
0.09
0.90 ±
0.09b
0.25 ±
0.02

0.41 ±
0.03b
0.42 ±
0.02b
0.67 ±
0.09
0.81 ±
0.13b
0.22 ±
0.02

3.61 ±
0.17
4.45 ±
0.19ab
7.45 ±
0.32ab
7.45 ±
0.34
2.93 ±
0.10a

3.85 ±
0.13
4.91 ±
0.12a
7.93 ±
0.23a
7.85 ±
0.24
3.09 ±
0.08a

3.28 ±
0.30
4.09 ±
0.35ab
6.54 ±
0.60ab
6.71 ±
0.56
2.57 ±
0.23ab

2.91 ±
0.35
3.66 ±
0.48b
5.73 ±
0.32b
6.13 ±
0.70
2.03 ±
0.27b

4.85 ±
0.36
4.78 ±
0.60
6.76 ±
1.57
8.82 ±
1.73
4.01 ±
0.33

5.56 ±
0.73
4.95 ±
0.58
6.03 ±
1.61
8.49 ±
1.84
4.34 ±
0.26

4.79 ±
0.28
5.10 ±
0.78
6.96 ±
1.44
8.96 ±
1.75
4.42 ±
0.36

4.87 ±
0.36
4.46 ±
0.49
5.95 ±
1.30
8.27 ±
1.55
4.19 ±
0.32

1.04 ±
0.07
ND

1.11 ±
0.06
ND

0.99 ±
0.08
ND

0.75 ±
0.09
ND

1.04 ±
0.07ab
0.19 ±
0.01a

1.11 ±
0.06a
0.21 ±
0.01a

0.99 ±
0.08ab
0.19 ±
0.01a

0.75 ±
0.09b
0.15 ±
0.01b

0.91 ±
0.02
0.46 ±
0.18

0.89 ±
0.04
0.50 ±
0.17

0.88 ±
0.01
0.59 ±
0.24

0.85 ±
0.01
0.51 ±
0.17

ND; not detected
Values are mean ± SEM of n = 8 rats/group. Different superscript letters a and b within the same row indicate significant difference at
p<0.05 by One-way ANOVA followed by Tukey’s test
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Table 4. Body composition of female rats fed 10% protein diets consisting of carp sarcoplasmic protein, casein, whey protein isolate,
or 2 weeks on 10% casein diet followed by a no-protein diet.
Tissue
CSP
Casein
WPI
No-Protein
Wet Weight (g)
Liver
8.45 ± 0.47a
8.48 ± 0.35a
9.54 ± 0.52a
5.4 ± 0.19b
Gastrocnemius Muscles
0.95 ± 0.03a
0.96 ± 0.05a
1.08 ± 0.07a
0.73 ± 0.05b
ab
a
ab
Soleus Muscles
0.47 ± 0.03
0.52 ± 0.02
0.41 ±0.03
0.48 ± 0.02b
Gonadal Fat Pad
2.62 ± 0.46b
3.26 ± 0.53ab
5.10 ± 0.68a
1.47 ± 0.35b
ab
ab
a
Retroperitoneal Fat Pad
1.85 ± 0.48
1.66 ± 0.44
2.22 ± 0.39
0.30 ± 0.08b
Right Kidney
0.88 ± 0.03a
0.82 ± 0.02a
0.93 ± 0.03a
0.59 ± 0.04b
ab
b
a
Left Kidney
0.89 ± 0.02
0.82 ± 0.02
0.95 ± 0.03
0.65 ± 0.05c
Heart
0.89 ± 0.03a
0.97 ± 0.09a
0.93 ± 0.04a
0.63 ± 0.03b
ab
ab
a
Lungs
1.45 ± 0.08
1.42 ± 0.08
1.51 ± 0.06
1.20 ± 0.08b
Brain
1.79 ± 0.04
1.62 ± 0.05
1.73 ± 0.09
1.72 ± 0.04
Adrenals
0.94 ± 0.33ab
0.67 ± 0.24ab
1.38 ± 0.39a
0.21 ± 0.06b
a
a
a
Thymus
0.64 ± 0.07
0.61 ± 0.04
0.61 ± 0.09
0.35 ± 0.04b
Spleen
0.43 ± 0.02a
0.46 ± 0.02a
0.52 ± 0.03a
0.27 ± 0.02b
Values expressed as mean ± SEM of n=8 rats/group. Different superscript letters a and b within the same row indicate significant
difference at p<0.05 by One-way ANOVA followed by Tukey’s test.
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Table 5. Measurements of kidney and bone health in female rats fed 10% protein diets consisting of carp sarcoplasmic protein, casein,
whey protein isolate, or 2 weeks on 10% casein diet followed by a no-protein diet.
CSP
Casein
WPI
No-Protein
Kidney Health Markers
Urinary Calcium Excretion (mg/week)
9.93 ± 3.95
21.72 ± 6.01
24.07 ± 8.36
10.19 ± 2.36
b
ab
ab
Kidney Total Calcium (mg/g)
0.36 ± 0.03
0.45 ± 0.01
0.46 ± 0.02
0.56 ± 0.04a
Serum
Blood Urea Nitrogen (mg/dL)
9.63 ± 1.55
11.50 ± 0.65
11.53 ± 2.09
10.01 ± 1.13
Calcium (mg/dL)
9.30 ± 0.43ab
10.50 ± 0.55a
10.48 ± 0.33a
8.51 ± 0.43b
a
a
a
Albumin (g/dL)
4.11 ± 0.16
4.16 ± 0.28
4.19 ± 0.49
2.63 ± 0.17b
Creatinine (mg/dL)
1.45 ± 0.05
1.40 ±0.08
1.39 ± 0.05
1.53 ± 0.11
Bone Health Markers
Morphometry
Femoral Length (mm)
27 ± 0.16a
26 ± 0.57a
26 ± 0.56a
22 ± 0.92b
Femoral Width (mm)
3.8 ± 0.04a
3.7 ± 0.06a
3.8 ± 0.04a
3.5 ± 0.05b
a
a
ab
Femoral Depth (mm)
2.8 ± 0.04
2.8 ± 0.04
2.8 ± 0.04
2.6 ± 0.04b
Femoral Dry weight (g)
0.549 ± 0.01a
0.51 ± 0.03a
0.491 ± 0.03a
0.363 ± 0.03b
Mineralization
Femoral Total Mineral Content (mg/bone) 190.27 ± 3.17a
178.46 ± 8.21a
173.96 ± 8.12a
128.80 ± 7.53b
Femoral Total Calcium (mg/g bone)
123.63 ± 2.59
127.22 ± 3.90
129.99 ± 3.12
129.73 ± 4.36
Femoral Total Phosphorous (mg/g bone)
73.42 ± 1.21
73.57 ± 1.24
77.18 ± 1.44
75.76 ± 2.08
Bone Strength
Femoral Peak Force (N)
126.68 ± 4.39
129.01 ± 6.40
137.98 ± 4.29
117.00 ± 7.08
Femoral Ultimate Bending Stress
(N/mm2)
38.41 ± 1.37
38.88 ± 2.71
42.18 ± 1.48
35.65 ± 2.78
Ultimate Stiffness (N/s)
440.46 ± 20.06
465.25 ± 21.45
459.95 ± 15.89
392.550 ± 33.44
Young’s Modulus (N/mm2)
2415.09 ± 124.99
2412.66 ± 140.52
2253.64 ± 127.73
1985.59 ± 239.67
Values expressed as mean ± SEM of n=5-8 rats/group. Different superscript letters a and b within the same row indicate significant
difference at p<0.05 by One-way ANOVA followed by Tukey’s test.
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Figure 1: Body weights of female rats fed 10% protein diets consisting of carp sarcoplasmic protein, casein, whey protein isolate, or 2
weeks on 10% casein diet followed by a no-protein diet. Values are mean ± SEM of n = 8 rats/group. Letters (a, b, c) shows
significant difference at p<0.05 determined by ANOVA followed by Tukey’s HSD.
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Supplemental Tables
Supplemental Table 1: Body composition corrected for body weight of female rats fed 10%
protein diets consisting of casein, whey protein isolate, carp sarcoplasmic protein, or 2 weeks on
10% casein diet followed by a no-protein diet.
NoTissue
CSP
Casein
WPI
protein
Relative Weight (g tissue/g body
weight)
4.18 ±
3.89 ±
Liver
4.15 ± 0.18 4.10 ± 0.14
0.17
0.15
0.49 ±
0.48 ±
Gastrocnemius Muscles
0.47 ± 0.02 0.46 ± 0.03
0.03
0.02
0.25 ±
Soleus Muscles
0.23 ± 0.01 0.26 ± 0.01 0.22 ± .01
0.02
1.28 ±
1.57 ±
2.31 ±
1.06 ±
Gonadal Fat Pad
b
ab
a
0.22
0.25
0.31
0.25b
0.91 ±
0.80 ±
1.01 ±
0.28 ±
Retroperitoneal Fat Pad
ab
ab
a
0.24
0.22
0.18
0.05b
0.43 ±
0.39 ±
Right Kidney
0.43 ± 0.01 0.4 ± 0.01
0.02
0.02
0.43 ±
0.41 ±
Left Kidney
0.44 ± 0.01 0.40 ± 0.01
0.01
0.02
0.42 ±
0.46 ±
Heart
0.45 ± 0.02 0.47 ± 0.01
0.02
0.02
0.72 ±
0.86 ±
Lungs
0.76 ± 0.05 0.69 ± 0.03
0.04
0.06
0.88 ±
0.84 ±
1.19 ±
Brain
0.79±0.03b
0.02b
0.06b
0.05a
0.01 ±
0.01 ±
Adrenals
0.01 ± 0.01 0.01±0.01
0.01
0.01
0.28 ±
0.25 ±
Thymus
0.32 ± 0.03 0.30±0.02
0.04
0.03
0.24 ±
0.20 ±
Spleen
0.21 ± 0.19 0.22±0.01
0.01
0.02
Values expressed as mean±SEM of n=8 rats/group. Different superscript letters a and b within
the same row indicate significant difference at p<0.05 by One-way ANOVA followed by
Tukey’s test
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Abstract
Consumption of high protein, milk-based infant formulas have been reported to increase
body weight gain and later life obesity risk resulting in the recommendation to lower protein
content. However, protein deficiency has been characterized by stunting and fatty liver due to
altered liver lipid metabolism. The objective of this study was to assess the effect low protein
diets from different sources on hepatic and adipose tissue lipid metabolism compared to a protein
deficient diet. Young (age 28 days) female Sprague-Dawley rats were randomly assigned (n=8
rats/group) to standard purified diet with 10% kcal protein as casein, whey protein, carp
sarcoplasm protein (CSP) or a protein deficient diet. Results showed whey-fed rats had the
greatest (p < 0.05) body weight and adiposity; however, there were no differences in gene
markers of lipogenesis, lipolysis or triglyceride synthesis and transport in adipose tissue. Caseinfed rats showed an anti-inflammatory response in adipose tissue indicated by upregulation of (p
< 0.05) of COX-2 and interleukin-10. Hepatic histology showed greater (p < 0.05) hepatic fat
infiltration were observed in rats fed the protein deficient diet while no differences in fat
infiltration among rats consuming CSP, casein or whey. Hepatic lipoprotein lipase (LPL) of
casein-fed rats was the only significantly (p < 0.05) altered biomarker in response to adipose
interleukin-10 production. Collectively, results indicate lower protein diets containing CSP and
casein is a physiologically safe option and may be preferable to whey protein for preventing
increased adiposity and with minimal alterations to gene expression.
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1. Introduction
Global fisheries currently operating close to maximal levels are at risk depleting fish
stocks (FAO, 2016). According to the Fishes and Aquaculture Organization (FAO), expansion of
aquaculture industries decreased by 3.3 %, while the global human populations is expected to
increase to 10 billion by 2050 (FAO, 2016). A potential solution to ensure fisheries sustainability
is to promote use of less desirable fish species and fish processing by-products.
Silver carp (Hypophthalmichthys molitrix) was imported into the United States in the
1970s to control algal growth in aquaculture and for sewage treatment ponds. Due to
unintentional introduction into the wild, carp has become an invasive species spreading into
various habitats and disrupting existing ecosystems (Chick 2001). Despite its abundance, silver
carp are underutilized as a food source due to their boniness making consumption and processing
into edible products difficult. A proposed solution to the problem of this invasive fish species is
to develop carp into a protein supplement for human consumption. Previous research
investigated the recovery of sarcoplasm protein from carp wash water and in vitro characteristics
of the resulting protein-rich silver carp sarcoplasmic protein powder (CSP) (Warren et al. 2018).
Subsequently, an animal feeding study showed CSP powder protein quality, bioavailability,
growth, and safety were comparable to commercially popular milk proteins, casein and whey
protein isolate (Warren et al., 2020).
Although, casein and whey protein have been used in infant formulas with long-term
commercial success compared to human milk, infant formulas often have higher protein content
(Tang, 2018). Higher body weight gains are common in formula-fed infants and has been
attributed to the higher protein content (Ong et al., 2009). This is a health concern since weight
gain during the first year of life has been suggested to be one of the strongest indicators of future
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risk of obesity (Ong & Loos, 2006). Previous research has reported whey-based formulas
promoted greater body weight gains by enhancing hepatic insulin like growth factor 1 (IGF-1)
secretion which mediates lipid synthesis in adipose tissue (Ong et al.,2009; O’Connell, 2013).
However, by lowering protein content of infant formulas this may be detrimental to growth and
liver function.
Protein-energy malnutrition is defined as an imbalance between intake of protein and
energy and the amount required for optimal growth, development, and function (Fock et al.,
2010; Bossola, 2015). Protein-energy malnutrition has been reported to alter liver histology and
biochemical characteristics (Caballero et al., 2015; Feres et al., 2010). Gomes and others (2017)
reported reduced liver weight and hepatocyte volume in protein undernourished mice. Further,
protein energy malnutrition has been characterized by fatty liver and hepatic dysfunction
(Zutphen et al., 2016). When the quantity of dietary protein is reduced, protein quality and
digestibility becomes more important for sustaining growth and metabolic function. Koletzko
and others (2009) reported infants fed diets containing high quality proteins in lower amounts
supported normal growth while reducing the risk of obesity development later in life.
The protein composition of wild carp was found to be 16.69% and to contain all 10
essential amino acids in quantities required for human needs (Ljubojević, 2017). Additionally,
marine derived proteins have been suggested to lower cardiovascular risk. An animal feeding
study found marine proteins reduced total serum cholesterol compared to casein by increased
cholesterol and bile acid fecal excretion (Narayan et al., 2009). Fish protein derived from cod
was found to lower liver triglyceride content and secretion compared to casein (Demonty et al.,
2003). In addition to its protein content, wild carp can have 7.13% lipid content with 72.64% of
fatty acids consisting of polyunsaturated fatty acids (PUFAs) with health-beneficial omega-3
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PUFAs (ω-3 PUFAs) being particularly abundant at 5.97% (Ljubojević, 2017). Omega-3 PUFAs
are often added to infant formulas for infant growth and development of visual and cognitive
function (Gil et al., 2003). Further, ω-3 PUFA supplementation has been reported to improved
fatty liver and hepatic dysfunction clinical markers in a meta-analysis of 18 studies consisting of
1,424 patients.
The objective of this study was to assess the effect of providing a low protein diet (10 %
kcal) consisting of CSP or commercial milk protein powders, whey and casein, on lipid
metabolism in liver and adipose tissue compared to a protein deficient diet using a rat model. We
hypothesize a low protein diet comprised of CSP will alter lipid metabolism resulting in reduced
adiposity and hepatic lipid accumulation compared to casein and whey protein.
2. Materials and Methods
2.1 Animals and Diets
All animal procedures were approved by West Virginia University’s Animal Care and
Use Committee and performed in accordance with National Research Council for the Care and
Use of Laboratory Animals Guidelines (National Research Council 1996). Immature (age 28
days) female Sprague-Dawley rats (n=32) were purchased from Charles River (Worcester, MA)
and individually housed in metabolic cages for the duration of the four weeks study. Following
7-day acclimation, rats (n=32) were randomly assigned to four diet treatment groups (n = 8
rats/group) consisting of purified standard rodent diet AIN-93G (American Institute of Nutrition93Growth) containing 10% kcal protein from different sources: (1) CSP for 4 weeks, (2) casein
for 4 weeks, (3) whey protein isolate for 4 weeks or, (4) a protein deficient diets comprised of
AIN-93G with 10% kcal casein for 2 weeks followed by protein deficient diet for the remaining
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2 weeks. Diet ingredients and composition are provided in Table 1. All experimental diets were
adjusted to be isocaloric (3.7-3.8 kcal/g).
Following establishment of a standard average food intake, rats were peer fed. To avoid
difference in caloric intake, rats were provided 16 ± 0.2 g diet daily. All diets and proteins,
casein and whey protein isolate were purchased from Envigo-Teklad (Madison, WI). Diets were
stored at -20oC until fed. Rats were provided deionized, distilled water (ddH2O) ad libitum. Body
weight and ddH2O intake were measured weekly.
Following 4 weeks of feeding, rats were fasted overnight (12 h) and euthanized via
carbon dioxide inhalation. Liver and gonadal fat pad were dissected. Tissues were weighed, flash
frozen in liquid nitrogen, and stored at -80oC for later analysis.
2.2 Diet and Tissue Lipid Content
Lipids were extracted from the experimental diets and tissues according to methods
described by Bligh and Dyer (1959). Briefly, experimental diets (1.0g) liver tissue (1.0g) and
gonadal adipose tissue (0.5 g) were homogenized in Tris/EDTA buffer (pH 7.4). Nonadecanoic
acid (50 µL) was added as an internal standard for fatty acid quantification followed by the
addition of a chloroform: methanol: acetic acid solution (2:1:0.15, v/v/v). Samples were
centrifuged at 900×g for 10 minutes at 10oC, and the chloroform layer (bottom layer) was
collected and filtered. The filtered chloroform layer was mixed with a chloroform:methanol
solution (4:1, v/v), centrifuged at 900×g for 10 minutes at 10oC, and the resulting chloroform
layer was collected and filtered. Extracted lipids were dried under nitrogen gas and total lipid
content was determined gravimetrically.
2.3 Diet and Tissue Fatty Acid Composition
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Following lipid extraction, fatty acids were transmethylated as described by Fritsche and
Johnston (1990). Briefly, fatty acids were methylated by adding a solution of 4% sulfuric acid in
anhydrous methanol to samples of extracted lipids. Samples were incubated for 60 minutes in a
90oC water bath, cooled to room temperature, and then the reaction was stopped using ddH2O.
Chloroform was added to the methylated samples and centrifuged at 900 x g for 10 minutes at
10oC. To remove remaining water, the collected chloroform layer was filtered through anhydrous
sodium sulfate. Fatty acid methyl esters (FAMEs) were dried under nitrogen gas, resuspended in
isooctane, and stored at -20oC until analysis.
Fatty acid methyl esters (FAMEs) were analyzed using gas liquid chromatography (CP3800; Varian, Walnut Creek, CA, USA). This involved an initial temperature of 140oC for 5
minutes increased by 1oC per minute to a final temperature of 220oC. FAMEs were separated
with a wall-coated open tubular fused silica capillary column (Varian, Walnut Creek, CA, USA)
with a CP-Sil 88 stationary phase and a nitrogen carrier gas. Total separation time was 56
minutes. To identify fatty acids, quantitative 37 Component FAMEs Sigma Mix (Supelco,
Bellefonte, PA) was used. Fatty acid identities were determined by retention time, quantified
using peak area counts, and reported as percent of total fatty acids.
2.4 Liver Histology
The left lateral lobe of the liver (n = 3) was removed and placed in 10% buffered
formalin for histology analysis. Extracted tissues were dehydrated with solutions of increasing
ethanol concentration (70-100%) in ddH2O then placed in xylene and embedded in paraffin. 8µm
sections from each were stained with eosin and hematoxylin. Hepatic fat accumulation was
graded using classification provided in Brunt, et al. (1999). Grade 0 indicated no presence of fat
vacuoles, grade 1 indicated fat vacuole presence in less than 33% of hepatocytes, grade 2
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indicated presence in 33-66% of hepatocytes, and grade 3 indicated evidence of fat vacuoles in
greater than 66% of hepatocytes. Slides were analyzed with a Nikon TE 2000-S light microscope
(Nikon Instruments, New York, NY) at 10x magnification by a trained investigator blinded to
group identities. Images were captured using a PC interface with Q-Capture imaging software
(Quantitative Imaging Corporation, BC, Canada).
2.5 RNA isolation and gene expression
Total RNA was extracted from frozen liver and gonadal adipose tissue using the Zymo
Research mRNA Isolation Kit (Irvine, CA, USA) according to manufacturers’ instructions.
Isolated RNA was quantified by spectrophotometry (NanoDrop 100; Thermo Scientific,
Waltham, MA, USA) and integrity was visualized on a 1.5% agarose gel. Isolated RNA was
treated with DNase I with a TURBO DNA-free kit (Applied Biosystems, Foster City, CA, USA).
Real-time quantitative polymerase chain reaction (RT-qPCR) was used to amplify total
mRNA using the Superscript III First-Strand Synthesis System with oligo dT primers for
Carbohydrate-response element-binding protein (ChREBP), Sterol regulatory element-binding
protein-1c (SREBP-1c), Sterol regulatory element-binding protein-2 (SREBP-2), fatty acid
synthase (FAS), Stearoyl-CoA desaturase-1 (SCD-1), Peroxisome proliferator-activated receptor
alpha (PPARα), peroxisome proliferator-activated receptor gamma (PPARγ), hormone sensitive
lipase (HSL), diacylglycerol O-acyltransferase 2 (DGAT2), lipoprotein lipase (LPL), microsomal
triglyceride transfer protein (MTTP), cyclooxygenase 2 (COX-2), interleukin 10 (IL-10), and
nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB). House-keeping genes
included β-actin and GAPDH (Invitrogen, Carlsbad, CA, USA). Primers were designed using the
Primer3 program (Howard Hughes Medical Institute) and respective mRNA sequences from the
NCBI database. Forward and reverse primers for gene transcription are provided in Table 1.
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RT-qPCR of liver and gonadal adipose tissues used 2.5 µL of SYBR Green Master Mix
(Applied Biosystems, Foster City, CA, USA), 1 µL of cDNA (diluted 1:10), 1 µL of forward and
reverse primer solutions (10 µM each), and 0.5 µL ddH2O for a 5 µL total reaction volume.
Thermal cycling included 2 minutes at 50oC, 10 minutes at 95oC, and then 40 cycles of 15
seconds at 95oC and 1 minute at 60oC. A melt curve analysis was utilized following cycling.
2.6 Serum Biochemical Markers
Prior to euthanasia by carbon dioxide inhalation, rats were fasted overnight. Blood was
collected by cardiac puncture and centrifuged at 1500 × g at 4°C for 10 min to separate serum.
Serum was collected and stored at -80°C until analyzed. Alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) were measured to assess hepatic function by enzymatic
colorimetric assays using a commercially available Vet- 16 rotor. Absorbance was measured at
595 nm by Hemagen Analyst automated spectrophotometer (Hemagen Diagnostics Inc.,
Columbia, MD).
A commercially available fluorometric assay (Cell Biolabs, San Diego, CA, USA) was used
to determine serum total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C/VLDLC), and high-density lipoprotein-cholesterol (HDL-C). Briefly, serum (200 µL) was mixed with
precipitation reagent (200 µL) and centrifuged for 20 minutes at 2000 × g. The HDL-C
containing supernatant was collected and diluted (1:50) with reaction buffer. The LDL-C/VLDLC pellet was resuspended and diluted (1:50) with reaction buffer. Samples were transferred into a
96-well plate and incubated for 45 minutes. Excitation at 570 nm and emission at 590 nm was
measured with a microplate reader (BioTek Instruments Inc., Winooski, VT).
A colorimetric assay purchased from Cayman Chemical (Ann Arbor, MI, USA) was used
to determine serum triglycerides. Briefly, serum samples (10 µL) were aliquoted in duplicate into
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a 96-well plate and mixed with 150 µL of diluted enzyme solution to imitate the reaction.
Following bench top incubation for 45 minutes, absorbance at 540 nm was measured using a
microplate reader (BioTek Instruments Inc., Winooski, VT).
2.7 Statistical Analysis
All results are expressed as mean ± standard error of the mean (SEM). Gene expression
was analyzed as a function of mRNA abundance (A) using the following formula derived from
Jacometo et al. (2014):
𝐴=1

1
𝐸𝑔.𝑜.𝑖 𝐶𝑇,𝑔.𝑜.𝑖. − 𝐸ℎ.𝑘. 𝐶𝑇,ℎ.𝑘.

Where Eh.k.CT,h.k. is the average of the expression of the housekeeping genes:
𝐸ℎ.𝑘. 𝐶𝑇,ℎ.𝑘. = 0.5 (𝐸𝐺𝐴𝑃𝐷𝐻 𝐶𝑇,𝐺𝐴𝑃𝐷𝐻 + 𝐸𝐴𝐶𝑇𝐵 𝐶𝑇,𝐴𝐶𝑇𝐵 )
Data for each treatment group was log-transformed prior to statistical analysis and
significant differences were determined by one-way analysis of variance (ANOVA). Post-hoc
Tukey’s test was used with p < 0.05 signifying statistically significance. Statistical analyses were
performed using SAS JMP Pro 12.0 (SAS Institute Inc., NC, USA).
3. Results
3.1 Fatty Acid Composition of Diets
As shown in Table 2, fat content of all experimental diets was ≈7 % kcal. The fatty acid
profile of experimental diets is shown in Table 3. Palmitoleic acid (16:1) was present in the CSP
diet, but not the other protein diets. There was no other significant difference in saturated fatty
acid (SFAs), monounsaturated fatty acid (MUFAs), or essential fatty acid, linoleic acid and αlinoleic acid, content between any of the experimental diets. Arachidonic acid, eicosapentaenoic
acid, and docosahexaenoic acid were determined to be negligible in all experimental diets.
3.2 Food Intake, Body Weight and Tissue Weight
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Feeding whey protein for 4 weeks resulted in greater (p < 0.05) final body weight
compared to CSP and casein. There were no body weight differences between the casein and
CSP-fed rats. Body weight was significantly reduced in rats provided a protein deficient diet for
two weeks (Figure 1). There were no differences in total diet intake and caloric intake among
dietary protein groups. However, feed efficiency was significantly greater (p < 0.05) in rats fed
whey protein compared to rats fed CSP. Rats fed a protein deficient diet had the lowest (p <
0.05) feed efficiency (Table 4).
Rats fed whey protein had greater (p < 0.05) gonadal fat pad weight compared to rats fed
CSP and protein-free diet. Liver weight was significantly heavier (p < 0.05) for rats fed 10%
protein as CSP, casein, and whey protein compared to the protein deficient group. However,
differences were no longer significant after corrected for body weight.
3.3 Liver Histology
Liver histology identified <33% fat vacuoles in the hepatocytes in 100% of rats fed CSP
compared to 33% of rats fed casein or whey protein. Greatest hepatic fat infiltration was
observed in rats fed the protein deficient diet. In the protein deficient group, approximately 33%
of rats showed 33–66% fat vacuoles in hepatocytes and 66% showed fat vacuoles in <66% of
hepatocytes (Figure 3). There was an overall significant (p=0.0327) difference among histology
scores.
3.4 Liver Lipid Content and Fatty Acid Composition
As shown in Table 5, rats fed the protein deficient diet had greater (p < 0.05) total
hepatic lipid content compared to rats fed 10% protein as either CSP, casein or whey-protein.
Rats fed a protein deficient diet had the lowest hepatic stearic acid (18:0) content and the highest
(p < 0.05) hepatic oleic acid (18:1), linoleic acid and α-linoleic content. The liver of rats fed
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protein deficient diet contained arachidonic acid (0.14 ± 0.03) but was negligible in the hepatic
tissue of protein-fed rats. There were no differences (p > 0.05) in total lipid content and fatty acid
composition among rats fed different protein sources.
3.5 Hepatic Gene Expression
As shown in Table 6, gene expression of hepatic LPL was upregulated (p < 0.05) in rats
consuming casein. Conversely, consumption of the protein deficient diet downregulated (p <
0.05) hepatic LPL expression. There were no differences in expression of genes involved in
lipogenesis (ChREBP, SREBP-1c, SREBP-2, FAS, SCD-1), lipolysis (PPARα, PPARγ, HSL) or
expression of genes regulating triglyceride synthesis and transport (DGAT2, MTTP)
or inflammation (COX-2, IL-10, NFκB).
3.6 Adipose Lipid Content and Fatty Acid Composition
Shown in Table 7, there was no significant difference in gonadal adipose tissue total lipid
content or adipose tissue fatty acid composition among experimental diet groups.
3.8 Adipose Gene Expression
Shown in Table 8, there were no differences in expression of genes involved in lipogenesis
(ChREBP, SREBP-1c, SREBP-2, FAS, SCD-1), lipolysis (PPARα, PPARγ, HSL), or
triglyceride synthesis and transport genes (DGAT2, LPL, MTTP) among the experimental diet
groups. Adipose COX-2 expression was downregulated (p < 0.05) in rats fed CSP and protein
deficient diets. Gene expression of COX-2 was upregulated (p < 0.05) in adipose tissue of rats
consuming casein. Additionally, gene expression of IL-10 was upregulated (p < 0.05) in adipose
tissue of rats fed casein diet. Adipose IL-10 expression was downregulated (p < 0.05) in rats
consuming protein deficient diet. There were no gene expression differences in inflammatory
transcription factor (NFkB) among experimental diet groups.
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3.9 Serum Liver Enzymes, Cholesterol, and Triglycerides
Shown in Table 9, there were no significant differences in serum AST, ALT among
experimental diet groups. There were also no significant differences in serum triglycerides, total
cholesterol, HDL-C, and VLDL/LDL-C among experimental diet groups.
4

Discussion

4.1 Growth Parameters
As expected, growing rat fed the protein deficient (0% kcals) diet for 2 weeks had the
lowest body weight. Growing rats fed a low (10% kcal) protein diet derived from either fish or
dairy sources supported growth within the normal range according to the body weight chart for
female Sprague-Dawley provided by the animal vendor (Charles River, Worcester, MA).
However, rats fed whey protein had significantly heavier final body weights and gonadal adipose
compared to rats fed CSP despite no differences in caloric intake. Feeding growing rats 20% kcal
protein diets, Liaset and others (2009) reported higher body weight gain, but no differences in
adipose tissue weight in rats fed casein compared to fish protein. Whey protein was not
investigated. In the current study, higher gonadal adipose (p < 0.05) in rats fed whey protein
compared to CSP may be due to higher feed efficiency. Whey proteins remain soluble in the
stomach and pass rapidly into the intestine leading rapid delivery rates for peptides and amino
acids (Boirie et al., 1997). However, high whey protein intake has been suggested to contribute
weight gain in early life. Early weight gain has been reported to be one of the best indicators of
later risk of obesity (Ong & Loos, 2006).
In the current study, diets were isocaloric and nutrients were adjusted to have no
differences in dietary lipid content or fatty acid composition between experimental diets:
therefore, phenotypic differences were due to differences in protein sources. Amino acid analysis
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of our diets showed whey protein had the highest leucine and isoleucine content (Warren et al.,
2020). Branch chain amino acids have been reported to promote adipogenesis by stimulating
insulin and insulin like growth factor-1 (IGF-1) (Melnik, 2012). Additionally, leucine and
isoleucine play an important role in the synthesis of proteins and other nitrogenous compounds
that include molecules that regulate lipid metabolism (Nie et al., 2018). Based on the current
study results, growing rats fed a low protein diet as CSP was adequate to support growth and
decreased adipogenesis compared to whey protein.
4.3 Adipose Lipid Metabolism
To determine molecular mechanisms that may have contributed to adiposity in whey-fed
rats; we measured genes with potential to modulate adipose lipid content (hypertrophy) and
differentiation (hyperplasia). Peroxisome proliferator-activated receptors (PPARs) belong to a
ligand-activated nuclear hormone receptor superfamily and are known to regulate the expression
of numerous genes involved in fatty acid metabolism and adipocyte differentiation (Schoonians
et al., 1996). PPARγ is mainly expressed in adipose tissue where it has been shown to be an
essential component in adipocyte differentiation (Braissant et al., 1996; Tontonoz et al., 1994).
Our study found no differences in gene expression of PPARγ among diet groups suggesting
greater gonadal adipose tissue weight in rats fed whey protein was not the results of increased
adipose differentiation.
Lipid content of adipose tissue in rats provided the protein deficient diet were
numerically lower than whey and CSP-fed rats. Regulation of DNL is mainly at the
transcriptional level. Transcription factors SREBP-1c induces fatty acid synthesis and SREBP-2
is primarily responsible for cholesterol uptake (Song et al., 2018). The present study showed rats
fed a deficient or low protein diet from different sources had no significant effect on SREBP-1c
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and SREBP-2 gene expression. This is because SREBP role in adipocyte DNL is minor. Instead,
ChREBP is a major lipogenic transcription factor in adipocyte DNL (Song et al., 2018). In DNL,
the key rate-limiting enzyme FAS converts malonyl-CoA into the first fatty acid product in DN,
palmitic acid. In turn, palmitic acid (16:0) undergoes elongation to stearic acid (18:0) and
desaturation by SCD-1 to palmitoleic acid (16:1) and oleic acid (18:1). Feeding 0% protein or
10% casein, CSP, and whey protein diets had no significant effect on adipose ChREBP, FAS,
SCD-1 gene expression or end products: palmitic, stearic, palmitoleic and oleic acid content.
DNL is balanced by lipolysis and therefore, a reduction in adipocyte lipolysis may
contribute to hypertrophy. In the current study, rats fed low casein, CSP, and whey protein diets
had no significant effect on gene expression of HSL and PPARα in gonadal adipose. Absence of
significance may be because PPARα has been reported to play a more important role in brown
rather than white adipose tissue in rats (Barbera et al., 2001; Atgie et al., 1997). In our study
there were also no difference among experimental diet groups in expression of genes regulating
triglyceride synthesis, transport, and storage, DGAT2, MTTP, and LPL. Blais et al. (2017)
evaluated changes induced by reducing dietary protein from standard 20% to low 6% kcal using
either soy protein or casein. The low soy protein was lower in methionine (230 g) compared to
casein (1.03 g) and showed increased energy expenditure (Blais et al., 2017). In our study,
absence of differences in adipose DNL markers may be attributed to methionine content of the
CSP, casein and whey protein diets of 17, 27, and 24 mg/g protein, respectively (Warren et al.,
2020).
There was no significant difference in gene expression of NFκB transcription factor
regulating COX-2 in the adipose tissue of rats fed CSP protein compared to whey protein or
casein. However, a review conducted by Liddle et al. (2017) suggested eicosapentaenoic acid
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and docosahexaenoic consumption shifts the adipose tissue immune cell population toward a less
inflammatory phenotype as suggested by the reduced macrophage ratio and increased antiinflammatory IL-10 production. In the present study, there were no significant differences in IL10 between rats fed 10% protein as either CSP, whey protein or casein. However, gene
expression of IL-10 was upregulated (p < 0.05) in rats fed casein compared to rats fed a protein
deficient diet.
Collectively, results indicate low dietary protein provided from dairy or fish source had
minimal effects on adipose lipid metabolism and inflammation in growing rats. However,
Pezeshski et al. (2016) reported immature obesity-prone Sprague-Dawley rats fed protein
restricted diets consisting of 10% kcal egg protein resulted in greater liver fat content indicative
of hepatic steatosis despite lack of increased total body fat. Therefore, the present study also
investigated the effects of low protein diets from different sources on hepatic lipid metabolism in
using immature Sprague-Dawley rats.
4.2 Liver Metabolism
NAFLD is defined as fat vacuoles in > 5% of hepatocytes evaluated by light microscopic
examination of a hematoxylin and eosin stained liver section (4–5 μm thick) under a 10×
objective lens (Sanyal et al., 2011). In the present study, all rats showed evidence of NAFLD.
Rats fed the protein deficient diet showed the greatest accumulation of lipids in the liver as
evident by the majority of rats having fat vacuoles in >66% of hepatocytes and the greatest (p <
0.05) hepatic total lipid content. Hepatic fat infiltration was lower in rats fed low protein diets
with fat vacuoles in <33% of hepatocytes. Further, hepatic fat infiltration differed depending on
protein source. Rats fed casein and whey protein showed less evidence of liver steatosis
compared to rats fed CSP.
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NAFLD has been characterized by liver steatosis and dysregulation of lipid metabolism
(Lonardo et al., 2015). ChREBP, SREBP-1c and SREBP-2 are transcription factors involved in
the regulation of DNL. Hepatic DNL is initiated with FAS producing the SFAs, palmitic (16:0)
and stearic acids (18:0). Subsequently, SCD-1 can desaturate these fatty acids producing
MUFAs, palmitoleic (16:1n-7) and oleic acids (18:1n-9). In our study, hepatic fatty acid
composition showed rats fed the protein deficient diet had lower (p < 0.05) stearic acid and
greater oleic acids than protein-fed rats. However, rats fed the protein deficient diets did not
exhibit differences in expression of DNL gene markers compared to the protein-fed groups.
Additionally, DNL transcription factors and enzymes gene expression did not differ among the
protein-fed rats regardless of source. Subsequently, there were also no differences in liver DNL
end products: palmitic, stearic, palmitoleic, or oleic acids among rats fed protein diets.
In the absence of DNL alterations, reduced lipolysis may explain the greater liver
steatosis. In lipolysis, HSL catalyzes the conversion of diacylglycerols to monoacylglycerols
(Lee et al., 2015). In the liver, transcription factors, PPARα and PPARγ, regulate of lipolysis and
lipid oxidation. Upregulation of PPARα and PPARγ enhance the use of lipids for metabolism
and have been targets for NAFLD therapeutics (Kersten et al., 2000; Fuchs et al., 2014). In the
current study, there were no differences in expression in HSL PPARα and PPARγ among the
experimental diet groups.
Other key characteristics of NAFLD were dysregulation of triglyceride synthesis,
transport, and storage (Romeo et al., 2008). DGAT2 is the rate limiting step in the biosynthesis
of hepatic triglyceride production and increase DGAT2 activity contribute to liver steatosis
(Wang et al., 2010). To prevent excessive liver storage, triglycerides are packaged into VLDL
for transport to extrahepatic tissue by MTTP. In our study, hepatic gene expression of DGAT2
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and MTTP did not differ among diet groups. However, hepatic LPL expression was increased in
the casein-fed rats compared to rats fed a protein deficient diet.
LPL is the rate limiting enzyme in the hydrolysis of triglycerides in chylomicrons and
VLDL that allows uptake of fatty acid acids by tissues (Goldberg, 1996). LPL is typically only
found in extrahepatic tissues with greater concentrations found in adipose and muscle tissues
(Semenkovich et al., 1989). In a human clinical study, Pardina et al. (2009) report in expression
of hepatic LPL mRNA is significantly elevated in subjects with NAFLD compared to subjects
with no liver disease. LPL overexpression in mouse liver causes liver-specific insulin resistance
and exacerbates triglyceride accumulation in the liver (Kim et al., 2001). Therefore, our data
suggests that rats consuming casein-based low protein diets may be at greater risk for the
development of fatty liver. Furthermore, Hardardottir et al. (1994) reported that cytokines can
induce liver LPL expression in adults.
Inflammation and reactive oxygen species from fatty acid metabolism promotes NAFLD
progression to non-alcoholic steatohepatitis (NASH) (Michelotti et al., 2013). The transcription
factor NFκB, is a key regulator in COX-2 expression and subsequent pro-inflammatory
responses (Lee at al., 2015; Lim et al., 2001). COX-2 catalyzes the conversion of arachidonic
acid to pro-inflammatory prostaglandins. In our study, there were no differences in NFκB or
COX-2 hepatic expression among experimental diet groups. Additionally, there were no
differences in liver damage serum biomarkers ALT and AST among protein-fed rats.
Additionally, NASH has been associated with lipoprotein dysregulation (Suzuki et al., 2017).
However, in the present study, there were no differences in serum triglyceride, VLDL, and LDL
levels among experimental diet groups. Absence of inflammation, hepatic damage, and lipid
dysregulation in experimental diet groups indicated NAFLD did not progress to the more severe
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NASH. Further suggesting low inflammatory status among the experimental groups, there were
no differences in IL-10 expression. IL-10 has been suggested to be one of the most important
anti-inflammatory cytokines (Stenvinkel et al., 2005).
Conclusion
Based on the results, CSP showed merit for commercial use in low protein formulas. Unlike
whey protein, CSP consumption did not elevate body weight or adiposity. Instead, CSP
demonstrated properties comparable to casein. Additionally, consumption of low CSP did not
alter expression of genes regulating lipid metabolism as was observed in rats fed casein that
contribute to NAFLD development or inflammation that promotes progression to NASH. Based
on our animal study, CSP is not only a physiologically safe option, but may be preferable to
whey protein for preventing increased adiposity. Branch chain amino acids in whey protein
isolate may have stimulated insulin and IGF-1 resulting in adipogenesis. However, more studies
are needed. Based on study results, sarcoplasm protein recovered from wash water from
processing of carp, an invasive species could be marketed as a sustainable novel protein
alternative to current commercial protein powder
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Figure and Tables

Table 1: List of primers used for RT-qPCR analysis.
Gene
NCBI Accession Number Forward Primer
Reverse Primer
ChREBP
NM_133552.1
5' CCTTAATGGGATGGTGTCT 3'
5' AGAGCAGGGCAGGGAACAGTA 3'
SREBP-1c NM_001276707.1
5' GCCTGCTTGGCTCTTCTCT 3'
5' GCTTGTTTGCGATGTCTCC 3'
SREBP-2 NM_001033694.1
5' TGATGCCGACTCTACTGCTG 3'
5' CACGAAGACGCTCAAGACAA 3'
FAS
NM_017332.1
5' GCTGCTACAAACAGCACCATC 3'
5' TCCACTGACTCTTCACAGACCA 3'
SCD-1
NM_139192.2
5' TTCGCCACTGACTTGCTATG 3'
5' CAGGAGGTTCTTGGGATGATT 3'
PPARα
NM_013196.1
5' ATGAACAAAGACGGGATGCT 3'
5' AGGAACTCTCGGGTGATGAA 3'
PPARγ
NM_013124.3
5' GCAAAGACAACAGACAAATCACC 3' 5' CGAAACTGGCACCCTTGA 3'
HSL
NM_012859.1
5' TCTCCAAGTGTGTAGCGCCTA 3'
5' AACTCCAGGAAGGAGTTGAGC 3'
MTTP
NM_001107727.1
5' TCAGGTGCTGTGTATTCTGCT 3'
5' CGTGTTCCACTTCCGTTCT 3'
DGAT2
NM_001012345.1
5' CACCCTCCTGTGTATTCTGCT 3'
5' TTTGGCTGTTCTTGTTTCCA 3'
LPL
NM_012598.2
5' CGCTCCATCCATCTCTTCAT 3'
5' TTTCTCAAATGCCTCCTTGG 3'
NFκB
NM_001145138.2
5’ TTATGGGCAGGATGGACCTA 3’
5’ CCTTTCAGGGCTTTGGTTTA 3’
COX-2
NM_017232.3
5’ CGGAGGAGAAGTGGGTTTTAG 3’
5’ TGAAAGAGGCAAAGGGACAC 3’
IL-10
NM_012854.2
5’ CACTGCTATGTTGCCTGCTC 3’
5’ GCCTTTGCTGGTCTTCACTC 3’
β-actin
NM_031144.2
5' TTGCTGACAGGATGCACAAG 3'
5' CAGTGAGGCCAGGATAGAGC 3'
GAPDH
NM_017008.4
5' TCAAGAAGGTGGTGAAGCAG 3'
5' CCTCAGTGTAGCCCAGGATG 3'
Abbreviations: ChREBP, carbohydrate-response element-binding protein; SREBP-1c, Sterol regulatory element-binding protein-1c;
SREBP-2, Sterol regulatory element-binding protein-2; FAS, fatty acid synthase; SCD-1, Stearoyl-CoA desaturase-1; PPARα,
Peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome proliferator-activated receptor gamma; HSL, hormone sensitive
lipase; DGAT2, diacylglycerol O-acyltransferase 2; LPL, lipoprotein lipase; MTTP, microsomal triglyceride transfer protein; COX-2,
cyclooxygenase 2; IL-10, interleukin 10; NFκB, nuclear factor kappa-light-chain-enhancer of activated B cells; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase.
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Table 2: Composition of rodent diets substituted with 10% kcal protein of
carp sarcoplasmic protein, casein or whey protein isolate.
Treatments1
CSP
Casein Whey
No-Protein
Ingredient (g/kg)
Whey Protein Isolate
111
Casein
115
Carp Protein
131.5
Corn Starch
482.236 492.036 495.286
605.986
Maltodextrin
132
132
132
132
Sucrose
100
100
100
100
Soybean Oil
66.5
70
70
70
Cellulose
50
50
50
50
Mineral Mix
13.4
13.4
13.4
13.4
Calcium Phosphate
0.75
9.8
13.2
13.4
Calcium Carbonate
11.1
5.25
2.6
2.7
Vitamin Mix
10
10
10
10
Choline Bitartate
2.5
2.5
2.5
2.5
TBHQ, antioxidant
0.014
0.014
0.014
0.014
Macronutrients (% kcal)
Protein
10
10
10.3
0
Carbohydrate
66.9
67.8
68.1
78.1
Fat
7
7.1
7
7
Calories (kcal/g)
3.7
3.8
3.8
3.8
Abbreviations: CSP, carp sarcoplasmic protein; TBHQ, tert-butylhydroquinone
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Table 3: Fatty acid analysis of rodent diets substituted with 10% kcal protein of carp sarcoplasmic protein,
casein or whey protein.
Treatments1
Measurements (%)
CSP
Casein
Whey
No-Protein
SFAs
Palmitic acid 16:0
10.94 ± 0.73 10.61 ± 0.10 11.07 ± 0.16 10.98 ± 0.15
Stearic acid 18:0
4.09 ± 0.27 3.87 ± 0.14 4.13 ± 0.05 3.92 ± 0.20
MUFAs
Palmitoleic acid 16:1
0.18 ± 0.09a 0.00 ± 0.00b 0.00 ± 0.00b 0.00 ± 0.00b
Oleic acid 18:1n9c
18.10 ± 0.95 20.11 ± 1.96 18.95 ± 0.51 19.65 ± 0.25
PUFAs
Linoleic acid 18:2n6c
41.13 ± 2.12 48.79 ± 2.60 43.89 ± 0.51 47.43 ± 2.20
α-linoleic acid C18:3n3
5.72 ± 0.24 7.03 ± 0.54 6.12 ± 0.17 6.77 ± 0.46
Arachidonic acid C20:4
0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Eicosapentaenoic acid C20:5n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Docosahexaenoic acid 22:6n3
0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
1
Values expressed as mean ± SEM (n = 3 samples/diet). Different superscript letters a, b,
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed
by Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; MUFAs, monounsaturated fatty
acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids.
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Figure 1: Body weights of female rats fed 10% protein diets consisting of carp sarcoplasmic
protein (Carp), casein, whey protein isolate, or 2 weeks on 10% casein diet followed by a noprotein diet. Values are mean ± SEM of n = 8 rats/group. Letters (a, b, c) shows significant
difference at p < 0.05 determined by ANOVA followed by Tukey’s HSD.
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Table 4: Effect of the consumption of different diets substituted with 10% kcal protein consisting of carp
sarcoplasmic protein, casein or whey protein for four weeks on growth parameters of growing female rats.
Treatment1
Growth Parameters
CSP
Casein
Whey
No-Protein
Total diet intake (g)
449.98 ± 3.13a
441.65 ± 6.99a
460.49 ± 1.79a
380.59 ± 11.52b
Caloric intake (kcal)
1664.91 ± 43.78a 1678.26 ± 26.57a 1749.87 ± 43.77a 1446.24 ± 43.78b
Feed efficiency (g body wt/g diet intake)
0.16 ± 0.004b
0.19 ± 0.009ab
0.20 ± 0.006a
0.04 ± 0.007c
Final body weight (g)
202.85 ± 3.33b
207.26 ± 2.89b
219.66 ± 2.66a
141.70 ± 2.98c
b
ab
a
Total body weight gain (g)
73.93 ± 1.71
82.68 ± 4.04
93.69 ± 3.11
15.82 ± 2.75c
a
a
a
Liver weight (g)
8.45 ± 0.47
8.48 ± 0.35
9.54 ± 0.52
5.4 ± 0.19b
Relative liver weight (g / g bwt.)
4.15 ± 0.18
4.10 ± 0.14
4.18 ± 0.17
3.89 ± 0.15
b
ab
a
Gonadal fat pad weight (g)
2.62 ± 0.46
3.26 ± 0.53
5.10 ± 0.68
1.47 ± 0.35b
Relative gonadal fat pad (g / g bwt)
1.28 ± 0.22b
1.57 ± 0.25ab
2.31 ± 0.31a
1.06 ± 0.25b
1
Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c within the same row indicate
significant difference at p < 0.05 by one-way ANOVA followed by Tukey’s HSD. Abbreviations: CSP, carp sarcoplasmic protein.
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Measurement CSP Casein Whey No-protein
Steatosis Grade
0
2
2
1
3
1
1
2
1
3
2

Figure 2: Representative histological staining images of the liver of growing female rats fed
different proteins or no-protein diets. Arrows indicate locations of fat deposition. Scores
analyzed by chi-square test at p <0.05.
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Table 5: Effect of the consumption of different diets substituted with 10% kcal protein of carp
sarcoplasmic protein, casein or whey protein for four weeks on hepatic fatty acid composition
and total lipid content.
Treatments1
Measurements
CSP
Casein
Whey
No-Protein
SFAs (relative %)
Palmitic acid 16:0
19.12 ± 1.57 19.53 ± 0.50 18.17 ± 1.58 19.66 ± 0.94
19.88 ±
Stearic acid 18:0
1.29a
15.28 ± 1.71a 18.45 ± 0.79a 6.77 ± 0.43b
MUFAs (relative %)
Palmitoleic acid 16:1
1.03 ± 0.40
0.99 ± 0.27
0.95 ± 0.15
1.19 ± 0.08
10.18 ±
20.81 ±
Oleic acid 18:1n9c
1.99b
10.64 ± 1.96b 11.70 ± 0.94b
1.29a
PUFAs (relative %)
11.74 ±
23.21 ±
Linoleic acid 18:2n6c
1.31b
11.26 ± 2.07b 10.34 ± 0.62b
1.67a
α-linoleic acid C18:3n3
0.56 ± 0.06b 0.64 ± 0.10b 0.49 ± 0.04b 1.56 ± 0.09a
Arachidonic acid C20:4n6
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
0.14 ± 0.03
Eicosapentaenoic acid C20:5n3 0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
Docosahexaenoic acid 22:6n3
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
19.96 ±
Total Lipid Content (%)
6.91 ± 0.99b 8.73 ± 1.85b 4.62 ± 0.99b
4.13a
1
Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a and b
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed
by Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; MUFAs, monounsaturated
fatty acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids.
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Table 6: Effect of consumption of different diets substituted with 10% kcal protein of carp
sarcoplasmic protein, casein or whey protein for four weeks by growing female rats on hepatic
lipid metabolism gene expression.
Treatments1
Measurements
CSP
Casein
Whey
No-Protein
Lipogenesis
ChREBP
14.03 ± 3.91
19.5 ± 4.96
29.64 ± 5.99
19.22 ± 3.00
SREBP1c
2.4 ± 0.57
1.54 ± 0.50
2.08 ± 0.51
1.69 ± 0.58
SREBP2
3.79 ± 1.16
1.68 ± 0.82
2.68 ± 1.06
2.69 ± 0.76
FAS
0.19 ± 0.06
0.17 ± 0.074
0.38 ± 0.11
0.22 ± 0.06
SCD-1
2.16 ± 0.75
1.36 ± 0.40
2.05 ± 0.39
0.68 ± 0.33
Lipolysis
PPARα
0.79 ± 0.10
1.31 ± 0.35
1.46 ± 0.23
1.185 ± 0.24
PPARγ
1.05 ± 0.28
0.9 ± 0.32
1.22 ± 0.36
0.55 ± 0.13
HSL
0.2 ± 0.05
0.095 ± 0.02
0.13 ± 0.04
0.44 ± 0.16
Storage and Transport
DGAT2
1.92 ± 0.74
1.13 ± 0.21
3.14 ± 0.71
1.35 ± 0.69
ab
a
ab
LPL
1.09 ± 0.28
1.24 ± 0.25
0.78 ± 0.19
0.37 ± 0.09b
MTTP
1.29 ± 0.48
1.18 ± 0.48
1.31 ± 0.42
1.59 ± 0.42
Inflammation
COX-2
1.1 ± 0.51
0.26 ± 0.19
0.074 ± 0.03
0.43 ± 0.28
IL-10
0.43 ± 0.18
0.18 ± 0.07
0.17 ± 0.07
0.24 ± 0.12
NFκB
1.06 ± 0.21
1.01 ± 0.17
1.25 ± 0.32
1.01 ± 0.28
1
Values expressed as mean ± SEM (n = 6–8 rats/group) of transcript abundance (A) of gene of
interest relative to housekeeping genes β-actin and GAPDH. Different superscript letters a and b
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; ChREBP, carbohydrate-response
element-binding protein; SREBP-1c, Sterol regulatory element-binding protein-1c; SREBP-2,
Sterol regulatory element-binding protein-2; FAS, fatty acid synthase; SCD-1, Stearoyl-CoA
desaturase-1; PPARα, Peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome
proliferator-activated receptor gamma; HSL, hormone sensitive lipase; DGAT2, diacylglycerol
O-acyltransferase 2; LPL, lipoprotein lipase; MTTP, microsomal triglyceride transfer protein;
COX-2, cyclooxygenase 2; IL-10, interleukin 10; NFκB, nuclear factor kappa-light-chainenhancer of activated B cells;
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Table 7: Effect of the consumption of different diets substituted with 10% kcal protein of carp
sarcoplasmic protein, casein or whey for four weeks on gonadal adipose tissue fatty acid
composition and total lipid content.
Treatments1
Measurements
CSP
Casein
Whey
No-Protein
SFAs (relative %)
Palmitic acid 16:0
24.54 ± 0.80 24.38 ± 0.82 24.45 ± 0.48 23.56 ± 1.03
Stearic acid 18:0
3.91 ± 0.24 3.48 ± 0.11 3.90 ± 0.24 3.83 ± 0.22
MUFAs (relative %)
Palmitoleic acid 16:1
5.54 ± 0.30 5.84 ± 0.05 5.41 ± 0.27 5.29 ± 0.38
Oleic acid 18:1n9c
29.29 ± 1.43 29.69 ± 1.32 30.81 ± 0.91 29.57 ± 1.30
PUFAs (relative %)
Linoleic acid 18:2n6c
20.72 ± 0.72 21.80 ± 0.57 22.59 ± 0.86 21.92 ± 0.62
α-linoleic acid C18:3n3
2.17 ± 0.19 2.34 ± 0.12 2.31 ± 0.08 1.81 ± 0.12
Arachidonic acid C20:4
0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Eicosapentaenoic acid C20:5n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Docosahexaenoic acid 22:6n3
0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Total Lipid Content (%)
77.82 ± 5.56 73.66 ± 4.10 77.49 ± 2.62 66.57 ± 1.99
1
Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; MUFAs, monounsaturated fatty
acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids.
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Table 8: Effect of consumption of different diets substituted with 10% kcal protein of carp
sarcoplasmic protein, casein or whey protein for four weeks by growing female rats on lipid
metabolism gene expression in gonadal adipose tissue.
Treatments1
Measurement
CSP
Casein
Whey
No-Protein
Lipogenesis
ChREBP
1.33 ± 0.37
1.18 ± 0.29
1.22 ± 0.38
1.52 ± 0.40
SREBP1c
1.22 ± 0.4
1.18 ± 0.32
2.02 ± 0.51
1.95 ± 0.51
SREBP2
1.38 ± 0.37
1.03 ± 0.31
1.29 ± 0.22
1.43 ± 0.61
FAS
2.18 ± 0.69
5.55 ± 1.69
5.3 ± 1.43
4.49 ± 1.91
SCD-1
5.84 ± 2.18
3.42 ± 1.21
3.91 ± 1.42
1.59 ± 0.64
Lipolysis
PPARα
1.16 ± 0.36
1.50 ± 0.48
1.58 ± 0.54
2.72 ± 0.67
PPARγ
2.61 ± 0.90
2.27 ± 0.77
3.41 ± 0.95
2.36 ± 0.71
HSL
5.14 ± 1.97
3.84 ± 1.76
5.53 ± 1.73
6.62 ± 2.44
Storage and Transport
DGAT
0.25 ± 0.05
1.37 ± 0.47
1.88 ± 0.63
1.53 ± 0.48
LPL
2.07 ± 0.74
2.21 ± 1.07
3.3 ± 1.13
1.81 ± 0.72
MTTP
0.018 ± 0.018
0.74 ± 0.41
0.66 ± 0.17
0.34 ± 0.09
Inflammation
COX-2
0.0033 ± 0.001b
0.017 ± 0.0029a 0.0081 ± 0.0026ab 0.00051 ± 0.00025b
IL-10
0.0013 ± 0.0003ab 0.0025 ± 0.0006a 0.0019 ± 0.0004ab 0.00065 ± 0.00025b
NFκB
0.53 ±0.26
0.77 ± 0.38
0.58 ± 0.28
0.35 ± 0.09
1
Values expressed as mean ± SEM (n = 6–8 rats/group) of transcript abundance (A) of gene of
interest relative to housekeeping genes β-actin and GAPDH. Different superscript letters a and b
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; ChREBP, carbohydrate-response
element-binding protein; SREBP-1c, Sterol regulatory element-binding protein-1c; SREBP-2,
Sterol regulatory element-binding protein-2; FAS, fatty acid synthase; SCD-1, Stearoyl-CoA
desaturase-1; PPARα, Peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome
proliferator-activated receptor gamma; HSL, hormone sensitive lipase; DGAT2, diacylglycerol
O-acyltransferase 2; LPL, lipoprotein lipase; MTTP, microsomal triglyceride transfer protein;
COX-2, cyclooxygenase 2; IL-10, interleukin 10; NFκB, nuclear factor kappa-light-chainenhancer of activated B cells;
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Table 9: Effect of the consumption of different diets substituted with 10% kcal protein of carp
sarcoplasmic protein, casein or whey protein for four weeks on serum measurements of liver
function enzymes, cholesterol, and triglycerides.
Serum Measurements1 CSP
Casein
Whey
No-Protein
AST (U/L)
223.71 ± 34.01 195.83 ± 27.75 129.20 ± 20.27 163.33 ± 11.13
ALT (U/L)
80.63 ± 14.21
67.71 ± 7.48
63.71 ± 10.22
64.57 ± 5.99
VLDL-C/LDL-C (uM)
38.62 ± 7.37
38.83 ± 6.65
39.07 ± 8.07
19.54 ± 2.46
HDL-C (uM)
14.02 ± 4.48
14.31 ± 3.94
20.05 ± 8.35
11.25 ± 3.77
Total Cholesterol (uM)
52.64 ± 9.30
53.15 ± 5.97
59.12 ± 6.13
30.79 ± 4.49
Triglycerides (mg/dl)
100.95 ± 9.95 98.09 ± 10.12 112.78 ± 8.77 95.31 ± 12.99
1
Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; AST, aspartate aminotransferase;
ALT, alanine aminotransferase; VLDL-C, very low density lipoprotein cholesterol; LDL-C, low
density lipoprotein cholesterol; HDL, high density lipoprotein.
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Abstract
Whey-based infant formulas have been reported to increase body weight gain and obesity risk.
Protein content in infant formulas are often higher than human breastmilk resulting in elevated
secretion of insulin like growth factor-1 (IGF-1) leading to anabolic metabolism. Previously, we
determined water-soluble carp sarcoplasmic proteins (CSP) recovered in wash water to be a safe,
with nutritional and functional values comparable to milk proteins, casein and whey protein. The
objective of this study to investigate phenotypic and hepatic transcriptome responses due to low
protein (10% kcal) diets consisting of CSP or milk proteins. Young (age 28 days) female
Sprague-Dawley rats were randomly assigned (n=8 rats/group) to standard purified diet
providing 10% CSP, casein, whey protein isolate or a protein-free diet. Following 4 weeks of
feeding, liver total RNA was extracted from hepatic tissue samples. Total RNA samples of the
highest quality (n = 4 rats/groups) underwent RNA sequencing. RNA sequencing reads were
aligned, mapped, and assembled prior to differential gene expression. Transcripts per million for
genes involved in branch chain amino acid (BCAA) metabolism, IGF-1 signaling pathway, and
lipid metabolism were calculated for analysis. Whey protein isolate had the highest BCAA
content compared to casein and CSP. This corresponded with greater (p < 0.05) final body
weight and gonadal fat pad weight in whey protein compared to CSP and casein-fed rats.
Consumption of the protein-free diet resulted in the greatest number (1,814) of differentially
expressed genes compared to rats fed casein. Rats fed protein-free diet were separated from CSP,
casein, and whey protein-fed rats which were arbitrarily clustered together. Among protein diets,
abundance of IGF-1 transcripts were greater (p < 0.05) in rats consuming CSP and whey protein.
However, there were no differences in gene transcript abundance in BCAA metabolism and the
IGF-1 signaling cascade among diet groups. Collectively, results indicate diets with reduced

113

protein content (10% kcal) may not be sufficient to cause significant alterations to hepatic
transcriptome. However, greater expression of IGF-1 can affect extrahepatic nutrient storage in
adipose tissue.
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1. Introduction
According to the Food and Agriculture Organization of the United Nations (FAO), the global
consumption of fish and other aquatic animals has quadrupled in the past 50 years. However,
global fisheries are operating close to maximal levels with risk of depleting fish stock (FAO,
2016). The FAO reported 3.3 percent reduction of aquaculture industries while the global human
population is expected to exceed 10 billion by 2050 (FAO, 2016). To overcome limitations of
natural resources, solutions need to be developed such as, utilization of less desirable fish
species. Silver carp (Hypophthalmichthys molitrix) brought to the United States in the 1970s
were unintentionally introduced to the Mississippi River due to flooding. Since their
introduction, silver carp have become an invasive species (Chick 2001). Despite their abundance,
silver carp are underutilized due to their boniness making consumption and processing difficult.
However, silver carp could be processed into a nutritious, alternative protein source.
All fish exceed the requirement of having more than 12 % energy from protein to be
considered high in protein and are a good source of essential amino acids (Ruxton, 2011).
Warren et al. (2018) investigated the recovery, drying, and in vitro characteristics of a proteinrich silver carp sarcoplasm protein (CSP) powder. Results indicated no differences between the
CSP and milk proteins, whey and casein. Whey and casein are used in protein supplements and
infant formulas with long-term commercial success.
Ong and others (2009) reported greater body weight gains in formula-fed infants compared to
infants fed human milk due to increased insulin like growth factor 1 (IGF-1) and insulin
excretion. IGF-1 is a protein synthesized and secreted by the liver with major regulatory roles in
growth and metabolism by mediating the effects of growth hormone (GH). GH synthesis and
secretion of IGF-1 is dependent on nutritional status and hormones such as insulin (Daughaday
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and Rotwin, 1989). Diets low in protein have been shown to decrease plasma concentrations of
IGF-1 in growing pigs (Deng et al., 2007). Dietary branch chain amino acids (BCAA) have been
reported to induce IGF-1 excretion; however, the mechanism of action has not been well-studied.
Wan et al. (2017) reported greater expression of IGF-1 from amino acid supplementation as a
result of an interaction between mammalian target of rapamycin (mTOR), an important
intracellular sensor for cell growth and autophagy, and peroxisome proliferator-activated
receptor gamma (PPARγ), a transcription factors involved in the regulation of lipolysis.
However, more mechanistic studies are needed.
Compared to human milk, infant formulas often have higher protein content and is suggested
to contribute to risk of obesity (Tang, 2018). Weight gain during the first year of life is one of the
best indicators of later risk of obesity (Ong & Loos, 2006). This led to suggestions for infant
formulas to lower amounts of protein and use high quality proteins to reduced risk of developing
obesity later in life (Koletzko et al., 2009). Protein quality and physiological effects of proteins
varies depending on its source. Song and others (2016) reported protein from beef, chicken, pork
and carp sources in the recommended amount (18% by weight) for seven days resulted in distinct
gene expression and physiological responses. Carp consumption was shown to downregulate
genes regulating fatty acid oxidation and the synthesis of bile acids, triglycerides, and
cholesterol. Therefore, the objective of this study was to investigate distinct phenotypic and
hepatic transcriptome responses due to feeding low protein (10% kcal) diets consisting of CSP
and milk proteins, casein and whey, in an animal model using growing rats.
2. Materials and Methods
2.1 Animals and Diets
Immature (age 28 days) female Sprague-Dawley rats (n=32) were purchased from
Charles River (Worcester, MA) and individually housed in metabolic cages for 4 weeks.
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Following an acclimation period of 7-days, rats (n=32) were randomly assigned to four
experimental groups (n = 8 rats/group) of purified standard rodent diet AIN-93G (American
Institute of Nutrition-93Growth) consisting of different sources of protein: (1) AIN-93G with
10% kcal CSP for 4 weeks, (2) AIN-93G with 10% kcal casein for 4 weeks, (3) AIN-93G with
10% kcal whey protein for 4 weeks or, (4) AIN-93G with 10% kcal casein for 2 weeks followed
by protein free diet for 2 weeks. Table 1 shows diet ingredients and composition. All
experimental diets were isocaloric (3.7-3.8 kcal/g) with the only difference being protein source.
All animal procedures were performed in accordance with National Research Council for the
Care and Use of Laboratory Animals guidelines and approved by West Virginia University’s
Animal Care and Use Committee (National Research Council, 2011).
All diets as well as protein sources, casein and whey protein, were purchased from
Envigo-Teklad (Madison, WI). Diets were stored at -20oC between feedings, Distilled deionized
water (ddH2O) was provided ad libitum and replaced weekly. Rats were provided 20 g diet daily
until normal diet consumption was established. Rats were then peer fed 16 ± 0.20 g diet/d.
Following 4 weeks of feeding, rats were fasted overnight (12 h) and euthanized by carbon
dioxide inhalation. The liver was removed, perfused, weighed, flash frozen in liquid nitrogen,
and stored at -80oC for later analysis.
2.2 RNA isolation and RNA Sequencing
Total RNA was extracted from frozen hepatic tissue (50 mg) using the Zymo Research
mRNA Isolation Kit (Irvine, CA, USA) according to the manufacturer’s instruction for total
RNA isolation. Isolated RNA was treated with DNaseI with a TURBO DNA-free kit (Applied
Biosystems, Foster City, CA, USA) and sent for quality assurance via bioanalyzer (Agilent,
Santa Clara, CA).
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RNA samples with the highest quality (RIN ≥ 6.8) from each experimental group (n=4)
were selected for sequencing. Selected RNA samples were sent to Novogene Corporation (Chula
Vista, CA, USA) for cDNA library construction (~300 bp) and RNA sequencing analysis
(Illumina Platform PE150; Q30 ≥ 80%; 20M raw reads/sample). Briefly, data was imported into
the Cyverse Discovery Environment (Cyverse, Tucson, AR, USA). RNA-Seq reads were aligned
with RMTA v2.6.3 workflow by mapping reads to the Ensembl reference genome (vRnor_6)
with HISAT2 then assembled using Stringtie and count reads using feature counts with default
parameters.
Differential gene expression was conducted using the DESeq2 package R Studio to read
count tables. Similar to Song et al. (2016), experimental groups were compared to casein as a
control to simplify the interpretation of the differential expression results. Results from DESeq2
were imported into Ingenuity Pathway Analysis (Qiagen Inc, Germantown, MD, USA). The
enrichment map generated using the Comparison Analysis plugin within the IPA software with
the default settings with gene sets that passed conservative significant thresholds (p < 0.05, False
Discovery Rate (FDR) < 0.10). A hierarchical cluster analysis heat map was produced using the
feature counts with the R studio pheatmap package following log transformation. Transcripts per
million for genes involved in the BCAA metabolism, IGF-1 signaling pathway, and lipid
metabolism were calculated using Kallisto-0.42.3 application in the Cyverse discovery
environment. Transcripts of interest were chain amino acid amino transferase (BCAA-AT),
branch chain ketoacid hydrogenase (BCKA-DH), IGF-1, insulin like growth factor 1 receptor
(IGF-1R), ras homolog enriched in brain (RHEB), mTOR, sterol regulatory element-binding
protein-2 (SREBP-2), and peroxisome proliferator-activated receptor gamma (PPARγ).
2.2 Statistical analysis
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A completely randomized design was used in the animal feeding study with n = 8 rats per
experimental diet group. Results are expressed as mean ± standard error of the mean. One-way
ANOVA was used to determine differences among diet treatment groups. Post-hoc multiple
comparison tests were performed using Tukey’s test with treatment differences considered
significant at p<0.05 and tendency at p=0.08. Statistical analyses were performed using JMP
12.2 statistical software package (SAS Institute, Cary, NC).
3. Results
3.1 Dietary Amino Acid Profile and Growth
Whey protein isolate had the greatest BCAA content at 262 mg/g protein compared to
casein (222 mg/g protein) and CSP (148 mg/g protein) (Table 2). Leucine was the most
abundant BCAA for the CSP, casein, and whey protein diets at 63 mg/g protein, 94 mg/g protein,
and 143 mg/g protein, respectively.
As shown in Figure 1, whey protein-fed rats had greater (p < 0.05) final body weight
compared to rats fed CSP and casein. There were no body weight differences between casein and
CSP-fed rats. Rats fed casein followed by a protein deficient diet for two weeks had the lowest (p
< 0.05) final body weight. Rats were peer-fed therefore there were no differences in total diet
intake or caloric intake among protein diet groups.
Illustrated in Table 3, rats fed whey protein had greater (p < 0.05) gonadal fat pad weight
compared to CSP and protein-free fed rats. Liver weights were greater (p < 0.05) in rats fed 10%
protein as CSP, casein, and whey protein compared to the protein-free group. However,
following body weight correction, weight difference was no longer statistically significant.
3.2 RNA sequencing
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RNA sequencing resulted in 21,629 transcripts expressed in rat hepatic tissue (Table 4).
Whey protein-fed rats had more transcripts expressed (16, 994) compared to rats fed CSP, casein
or protein-free diet. There were 6 differentially expressed transcripts when all diet groups were
compared. Therefore, casein was used as a control to simplify the interpretation of the
differential expression results. There were minimal differentially expressed transcripts when CSP
and whey protein supplementation were compared to casein.
Consumption of the protein-free diet for 2 weeks resulted in the greatest number (1,814)
of differentially expressed genes when compared to casein-fed rats. The hierarchical cluster
analysis of expressed transcripts is provided in Figure 2. Rats fed protein free diet were
separated from rats fed CSP, casein, and whey protein which were arbitrarily clustered together.
Subsequently, there were no differences in the comparison pathway analysis of differentially
expressed genes among protein fed rats (Figure 3). Rats fed protein free diet resulted in the
enhancement of multiple pathways; however, PPAR and mTOR pathways were not enriched.
3.3 IGF-1 Pathway
Shown in Figure 5, there were no differences in transcript expression of genes involved
in metabolism of BCAA (BCAA-AT, BCKA-DH). Abundance of IGF-1 transcripts were greater
(p < 0.05) in rats consuming CSP and whey protein. However, there were no differences in
transcript abundance of genes involved in IGF-1 signaling (IGF-1R, RHEB, mTOR,),
lipogenesis (SREBP-2), and lipolysis (PPARγ).
Discussion
4.1 Dietary Amino Acid Profile and Growth
In the current study, growing rats fed a protein deficient (0% kcals) diet for 2 weeks had
the lowest body weight. Among protein diets, rats fed whey protein had significantly greater
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final body weight compared to rats fed either CSP or casein. All experimental diets were
isocaloric and adjusted for nutrients resulting in no differences in dietary lipid profile or content
and therefore, the only difference was protein type. Comparing amino acid profiles of
experimental diets showed whey protein diet had the greatest leucine and isoleucine content
(Warren et al., 2018). BCAAs (leucine, isoleucine, and valine) have been reported to promote
adipogenesis by stimulating insulin and IGF-1 (Melnik, 2012). In the current study, fat
deposition depended on the protein source with greater gonadal adipose weight in growing rats
consuming whey protein (Table 3). Others have suggested high whey protein consumption
contributes to obesity and weight gain in infant (Tang, 2018; Koletzko et al., 2009). Investigating
the effect of protein sources on fat deposition is important to further investigate since weight
gain during early life has been reported to be one of the best indicators of later risk of obesity
(Ong & Loos, 2006).
The current study results suggest differences in phenotype were a result of the different
protein sources. Leucine and isoleucine play an important role in the synthesis of proteins and
other nitrogenous compounds, including transcription factors involved in lipid metabolism
regulation (Nie et al., 2018). Therefore, RNA sequencing was used to identify the distinct hepatic
transcriptome responses leading to the phenotype differences in growing rats fed low protein
(10% kcal) diets provided as CSP or milk proteins, casein and whey.
4.2 RNA Sequencing
Minimal differences were identified among rat consuming different protein diet. The
results suggest CSP, casein, and whey protein had comparable effects on the hepatic
transcriptome. In contrast, Song et al., (2016) reported transcriptome alterations were not
significantly different in rats fed 18% kcal protein diets sourced from beef, chicken, pork and
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carp compared to casein as a control. Carp protein consumption had the greatest effects on gene
sets describing fatty acid oxidation and the synthesis of bile acids, triglycerides, and cholesterol.
No differences were reported in BCAAs and sulfur amino acids (cysteine and methionine)
content amount the meat protein powders. Since lipid profiles were not assessed the observed
alterations to lipid metabolism may have been a result of different dietary fatty acid. Our study
indicates reduced protein (10% kcal) diets with similar fatty acid profiles (Supplemental Table 1)
may not be sufficient to cause significant alterations to the hepatic transcriptome.
In our study, rats provided a protein free diets for two weeks altered the hepatic
transcription, as evident by the hierarchical cluster analysis and comparative pathway analysis.
Particularly, isoleucine and valine degradation pathways were enriched in rats fed the protein
free diet. Isoleucine and valine are branched chain as well as essential amino acids. Results
suggest catabolism of BCAA may have been enhanced to compensate for the synthesis of other
amino acids missing in the diet. Therefore, transcripts of genes involved in BCAA catabolism
were assessed.
4.2 Genes of Interest
Catabolism of BCAA is important to maintain numerous homeostatic processes such as
protein turnover and anabolism, fatty acid oxidation, and immune function (Knerr et al., 2012).
BCAA metabolism occurs in the mitochondrial matrix with distinct pathways for each BCAA
(McCalley et al., 2019). Following transport into the mitochondria, BCAAs undergo deamination
via BCAA amino transferase (BCAA-AT) producing 2-oxo-branched chain organic acids. Once
deamination occurs, BCAA alpha-keto acid dehydrogenase (BCAA-DH) produces branchedchain acyl-coenzymes through oxidative decarboxylation. These enzymes are common in
catabolism of all three BCAAs. Production of acetoacetate, acetyl-CoA, and propionyl-CoA via
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specific acyl-CoA dehydrogenases is the final step in BCAA catabolism (Knerr et al., 2012).
Products of BCAA catabolism can then entering the Kreb cycle for energy production. However,
end products of leucine and isoleucine catabolism are substrates for fatty acid synthesis
(Lehninger et al., 2013). Whey protein had higher leucine and isoleucine content which may
have contributed to greater adiposity. However, no differences were identified in transcript
abundance in BCAA-AT or BCAA-DH among experimental diets suggesting minimal
differences in BCAA catabolism among diet groups.
Previous research reported an increase secretion of IGF-1 potentiates greater body weight
gains in infants fed whey-based formulas (Ong et al.,2009). PPARγ was reported to be crucial for
gene expression of IGF-1 and is induced by amino acid concentration (Wan et al., 2017). PPARγ
is one of a group of transcription factors that regulate metabolism cell, development, and
differentiation (Ahmadian et al., 2013; Wright et al. 2014; Reynolds et al., 2015). Numerically,
PPARγ expression was lowest in rats fed whey protein. Conversely, rats consuming whey
protein and CSP diets resulted in greater (p < 0.05) IGF-1 transcript abundance compared to rats
fed the protein free diet. Numerically, rats consuming whey protein had more IGF-1 transcripts.
No differences were identified among diet groups when downstream molecules in the IGF-1
pathway such as mTOR, an amino acid sensor for promoting growth and development, as well as
SREBP-2, a regulator of de novo lipogenesis, were investigated (Jewell et al, 2013; Strable et al.,
2010). Results indicate IGF-1 expression, secretion and signaling pathway may have additional
modulators in the liver.
4. Conclusion
In conclusion, results showed feeding a low protein (10% kcal) diet consisting of whey
protein potentiates higher body weight and adipose deposition in growing rats. However, this
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district phenotypic response was not imitated in the hepatic transcriptome indicated by negligible
difference among protein-fed rats. Further, minimal differences in transcriptome abundance of
gene modulating BCAA catabolism and the IGF-1 signaling pathway were identified among diet
groups. However, IGF-1 transcript abundance was enhanced in CSP and whey protein-fed rats.
Collectively, results indicate diets with reduced protein content (10% kcal) may not be
sufficiently deficient to cause significant alterations to hepatic transcriptome. However, the
greater expression of IGF-1 may affect nutrient storage in extrahepatic tissues such as adipose
tissue.
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6. Figures and Tables
Table 1: Nutritional level and ingredient composition of experimental protein
diets.
Items
CSP
Casein Whey No-Protein
1
Selected Nutrient Information
Protein (%)
10
10
10.3
0
Carbohydrate (%)
66.9
67.8
68.1
78.1
Fat (%)
7
7.1
7
7
Energy (kcal/g)
3.7
3.8
3.8
3.8
1
Ingredient (g/kg)
Whey Protein Isolate
111
Casein
115
Carp Protein
131.5
Corn Starch
482.236 492.036 495.286
605.986
Maltodextrin
132
132
132
132
Sucrose
100
100
100
100
Soybean Oil
66.5
70
70
70
Cellulose
50
50
50
50
Mineral Mix
13.4
13.4
13.4
13.4
Calcium Phosphate
0.75
9.8
13.2
13.4
Calcium Carbonate
11.1
5.25
2.6
2.7
Vitamin Mix
10
10
10
10
Choline Bitartate
2.5
2.5
2.5
2.5
TBHQ
0.014
0.014
0.014
0.014
Abbreviations: CSP, carp sarcoplasmic protein; TBHQ, Tertiary
butylhydroquinone
1
Received from Envigo-Teklad (Madison, WI)
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Table 2: Amino analysis of carp sarcoplasmic protein, casein, and whey
protein powders
CSP1
Casein2 Whey2
Essential Amino Acid (mg/g protein)
Valine
47.21 ± 0.18
70
56
Leucine
62.96 ± 0.26
94
143
Isoleucine
38.23 ± 0.14
58
63
Threonine
32.13 ± 0.21
44
53
Methionine + Cysteine
26.35 ± 0.27
31
64
Phenylalanine + Tyrosine
64.74 ± 0.65
105
80
Lysine
74.46 ± 0.44
82
112
Histidine
43.62 ± 0.24
29
20
Tryptophan
11.49 ± 0.16
12
24
Arginine
37.72 ± 0.21
39
30
Total Essential Amino Acid
438.91
506
563
Non-essential amino acids (mg/g protein)
Alanine
48.86 ± 0.22
32
57
Glycine
51.07 ± 0.27
19
18
Serine
28.17 ± 0.28
56
45
Proline
23.31 ± 1.05
84
45
Aspartic Acid
81.58 ± 0.42
71
125
Glutamic Acid
83.74 ± 0.48
229
176
Tyrosine
23.21 ± 0.18
54
42
Cysteine
9.88 ± 0.03
4
40
Taurine
25.98 ± 0.45
ND
ND
Total NEAA
375.8
549
548
Abbreviations: CSP, carp sarcoplasmic protein; ND, no data
Values are mean ± SEM with n = 3 samples/group.
1
Based on Warren et al., 2018.
2
Received from Envigo-Teklad (Madison, WI)
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Figure 1: Body weights of female rats fed 10% protein diets consisting of carp sarcoplasmic
protein (Carp), casein, whey protein isolate, or 2 weeks on 10% casein diet followed by a
no-protein diet. Values are mean ± SEM of n = 8 rats/group. Letters (a, b, c) shows significant
difference at p < 0.05 determined by ANOVA followed by Tukey’s HSD.
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Table 3: Effect of the consumption of different diets substituted with 10% kcal protein of carp sarcoplasmic protein, casein or
whey for four weeks on growth parameters of growing female rats.
Treatment1
Growth Parameters
CSP
Casein
Whey
No-Protein
Caloric intake (kcal)
1664.91 ± 43.78a
1678.26 ± 26.57a
1749.87 ± 43.77a
1446.24 ± 43.78b
Final body weight (g)
202.85 ± 3.33b
207.26 ± 2.89b
219.66 ± 2.66a
141.70 ± 2.98c
b
ab
a
Total body weight gain (g)
73.93 ± 1.71
82.68 ± 4.04
93.69 ± 3.11
15.82 ± 2.75c
Liver weight (g)
8.45 ± 0.47a
8.48 ± 0.35a
9.54 ± 0.52a
5.4 ± 0.19b
Relative liver weight (g / g bwt.)
4.15 ± 0.18
4.10 ± 0.14
4.18 ± 0.17
3.89 ± 0.15
b
ab
a
Gonadal fat pad weight (g)
2.62 ± 0.46
3.26 ± 0.53
5.10 ± 0.68
1.47 ± 0.35b
Relative gonadal fat pad (g / g bwt)
1.28 ± 0.22b
1.57 ± 0.25ab
2.31 ± 0.31a
1.06 ± 0.25b
1
Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c within the same row indicate
significant difference at p < 0.05 by one-way ANOVA followed by Tukey’s HSD. Abbreviations: CSP, carp sarcoplasmic protein.
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Table 4: Statistics of transcript expression
Class
Total Transcripts
Expressed Transcripts
Expressed in CSP
Expressed in Casein
Expressed in Whey
Expressed in No Protein
Differentially expressed transcripts (p<0.05;
q<0.05)
Global
Carp to Casein
Whey to Casein
No Protein to Casein
1
# indicates the number of transcripts
2
% indicates the percentage

#1
32883
21629
16692
16764
16994
16947

%2
100
65.78
77.17
77.51
78.57
78.35

6
25
7
1814

0.03
0.12
0.03
8.39
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Figure 2: Hierarchical cluster analysis of expressed genes in rats fed 10% kcal protein
diets of carp sarcoplasmic protein (carp), casein, or whey and no protein (NP) diets for
4 weeks. The level of expression was calculated by log transforming feature counts and
compared among the diet groups (n=4). Highly expressed transcripts are red, lowly expressed
transcripts are blue.
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Figure 3: Comparison pathway analysis of differentially expressed genes in rats fed
carp sarcoplasmic protein (carp), whey or no protein diets compared to rats fed casein
as a control. Enriched pathways are red, suppressed pathways are blue.
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Figure 4: Effect of the consumption of different diets substituted with 10% kcal protein of
carp sarcoplasmic protein (carp), casein or whey for four weeks on hepatic transcript
abundance of genes involved in branch chain amino acid metabolism. Values expressed as
mean ± SEM (n = 4 rats/group). Abbreviations: BCAA-AT, branch chain amino acid
aminotransferase; BCAA-DH, branch chain amino dehydrogenase.
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Figure 5: Effect of the consumption of different diets substituted with 10% kcal protein of
carp sarcoplasmic protein (carp), casein or whey for four weeks on hepatic transcript
abundance of genes involved in the IGF-1 signaling pathway. Transcript abundance of
insulin-like growth factor 1 (A), insulin like growth factor 1 receptor (B), and downstream
regulatory molecules (C) were characterized. Values expressed as mean ± SEM (n = 4
rats/group). Different letters a and b indicate significant difference at p < 0.05 by one-way
ANOVA followed by Tukey’s test. Abbreviations: IGF1, insulin-like growth factor 1; IGF1R,
insulin-like growth factor 1 receptor; Rheb, Ras homolog enriched in brain; mTOR, mammalian
target of rapamycin; SREBP-2, sterol regulatory binding protein-2; PPARγ, peroxisome
proliferator-activated receptor gamma.
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7. Supplemental Table
Table 5: Hepatic fatty acid composition and total lipid content after consuming diets
substituted with 10% kcal protein of CSP, casein or whey protein for four weeks.
Measurements
SFAs (relative %)
Palmitic acid 16:0
Stearic acid 18:0
MUFAs (relative %)
Palmitoleic acid 16:1
Oleic acid 18:1n9c
PUFAs (relative %)

CSP

Treatments1
Casein
Whey

No-Protein

19.12 ± 1.57 19.53 ± 0.50 18.17 ± 1.58 19.66 ± 0.94
19.88 ±
1.29a
15.28 ± 1.71a 18.45 ± 0.79a 6.77 ± 0.43b
1.03 ± 0.40
10.18 ±
1.99b

0.99 ± 0.27

0.95 ± 0.15

10.64 ± 1.96b 11.70 ± 0.94b

1.19 ± 0.08
20.81 ±
1.29a

11.74 ±
Linoleic acid 18:2n6c
1.31b
11.26 ± 2.07b 10.34 ± 0.62b
α-linoleic acid C18:3n3
0.56 ± 0.06b 0.64 ± 0.10b 0.49 ± 0.04b
Arachidonic acid C20:4n6
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
Eicosapentaenoic acid C20:5n3 0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00
Docosahexaenoic acid 22:6n3
0.00 ± 0.00
0.00 ± 0.00
0.00 ± 0.00

23.21 ±
1.67a
1.56 ± 0.09a
0.14 ± 0.03
0.00 ± 0.00
0.00 ± 0.00
19.96 ±
Total Lipid Content (%)
6.91 ± 0.99b 8.73 ± 1.85b 4.62 ± 0.99b
4.13a
1
Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a and b
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; MUFAs, monounsaturated fatty
acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids.
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Chapter VI
Summary and Future Directions
Summary
During processing of silver carp, water-soluble sarcoplasmic proteins lost in wash water,
were recovered and freeze-dried into a protein-rich powder, CSP. For commercial and consumer
acceptance, protein quality and safety of CSP must be evaluated by comparing CSP to popular
commercially available proteins, casein and whey protein. Study 1 assessed the protein quality
of CSP and effects of low (10% kcal) protein diets consisting of CSP, casein, and whey protein
on growth, body composition, renal markers, and bone health. Results indicated protein quality
of CSP was comparable to casein and whey protein. Further feeding low (10% kcal) protein diets
supported rat growth within the normal range; however, whey protein-fed rats had greater
gonadal adipose weight. Study 2 investigated low protein (10 % kcal) diets consisting of CSP,
whey protein or casein effects on lipid metabolism in adipose tissue and liver compared to a
protein-energy malnutrition diet. Results demonstrated CSP and casein and did not result in
altered expression of genes regulating adiposity or liver lipid metabolism contributing to
development of NAFLD. However, it has been suggested that whey protein consumption
stimulates insulin and IGF-1 secretion, resulting in adipogenesis. Therefore, Study 3 assessed
distinct hepatic transcriptome responses due to low protein (10% kcal) diets supplemented with
CSP, casein, and whey protein compared to a protein-free diet. RNA sequencing of hepatic tissue
revealed consumption of the protein-free diet resulted in the greatest number of differentially
expressed genes compared to casein while CSP and whey protein consumption increased the
abundance of IGF-1 transcripts.
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Based on the results of the three studies, we concluded:
1. Carp protein powder derived wash water provides a source of high-quality protein that
may contribute to improved sustainability by reducing amount of protein consumed to
support adequate body growth without affecting renal and bone health.
2. CSP is a physiologically safe option but may be preferable to whey protein for
preventing increased adiposity without detrimental effects on the liver and therefore,
could be marketed as a sustainable alternative to current commercial protein powder.
3. In low protein diets reduced protein content to 10% kcal did not cause significant
alterations to hepatic transcriptome. However, greater hepatic expression of IGF-1 in
whey-fed rats can affect nutrient storage in extrahepatic tissues.

Future Direction
Further studies are needed to investigate whether reduced protein diets sources from carp,
casein, and whey alter nutrient storage in extrahepatic tissues by assessing transcriptome
responses in adipose tissue. Additional CSP safety studies are needed to assess allergic response
elicitation and potential heavy metal effects. Future pilot plant studies should investigate
alternative recovery and drying methods to improve processing efficiency. Finally, product
formulation testing should be done in order to bring the silver carp derived protein powder to
market.
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